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1.1 Trypanosomosis 
Trypanosomosis is a haemoprotozoan disease of humans and animals caused by several species 
of parasites of the genus Trypanosoma (CFSPH, 2009; FAO/IAEA, 1993; Nakayima et al., 2012). 
The parasite is mainly transmitted cyclically by the genus Glossina (tsetse flies), but also 
mechanically by several biting flies such as Tabanus and Stomoxys (Nakayima et al., 2012; OIE, 
2013a). The disease can affect various species of mammals but, from an economic point of 
view, tsetse-transmitted trypanosomosis, is particularly important in cattle. It is characterized 
by intermittent fever, parasitaemia, anaemia, lymphadenopathy, jaundice, progressive 
emaciation, weakness and reduced productivity. The transmission of this debilitating and fatal 
disease not only prevents the rearing of livestock for meat or as banking system, but also their 
use for traction in resource-poor regions like Ethiopia (Davila et al., 2003).  
 
1.2 Etiology  
Trypanosomes are flagellate protozoans that inhabit the blood plasma, the lymph and various 
tissues of their hosts (OIE, 2013a; Steverding, 2008). The genus Trypanosoma belongs to the 
protozoan branch, order Kinetoplastida and family Trypanosomatidae (CFSPH, 2009; OIE, 
2013a). Tsetse-transmitted trypanosomes belong to the salivarian section, subgenus 
Nannomonas for T. congolense, Duttonella for T. vivax and Trypanozoon for T. brucei ssp. (OIE, 
2013a). Six species of trypanosomes have been known to exist in Ethiopia and the most 
important trypanosomes, in terms of economic loss in domestic livestock are reported to be the 
tsetse transmitted species such as T. congolense, T. vivax and T. brucei. In addition, the closely 
related T. brucei subspecies, T. b. rhodesiense and gambiense cause human sleeping sickness. 
The other Trypanosoma species of importance are T. evansi of camels and T. equiperdum of 
horses (Getachew, 2005).  
 
The discriminatory power of molecular techniques reveals far greater levels of genetic diversity 
than acknowledged by current nomenclature (Adams et al., 2010). Recently, the application of 
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molecular and biochemical analysis such as isoenzyme profiles, DNA and RNA technology and 
molecular karyotyping have been used for the classification of the parasitic protozoa (Imam, 
2009). Table 1.1 below depicts details of the classification.  
  
In addition, several types of T. congolense have been distinguished by molecular biology; the 
most common and pathogenic one in cattle has been reported as the savannah type (large 
variation in pathogenicity within the savannah subgroup), the other ones (type forest and Kilifi 
or Kenya coast) have been found less pathogenic and have different host affinity (OIE, 2013b). 
 
1.3 Trypanosoma life cycle  
African trypanosomes alternate their life cycle between a vertebrate host and tsetse fly (a.o. 
Glossina spp.). These parasites cause human African trypanosomosis (HAT or sleeping sickness) 
and animal African trypanosomosis (AAT) (Dyer et al., 2013). The life cycle of T. congolense and 
T. brucei in the fly were described in the last century, but comparatively few details are  
available for Trypanosoma (Nannomonas) congolense, despite the fact that it is the most 
prevalent and widespread pathogenic species for livestock in tropical Africa (Peacock et al., 
2012). T. congolense has a complex life cycle: bloodstream forms (BSF) proliferate in the blood 
of the infected mammalian host and are ingested by tsetse during the blood meal, procyclic 
forms (PCF) differentiate in the insect midgut, migrate to the proboscis (mouth parts) where 
they attach as epimastigote forms (EMF) and finally differentiate into infective metacyclic forms 
(MCF) that are transmitted to a new mammalian host during the next blood meal (Coustou et 
al., 2010). When the fly takes up bloodstream form trypanosomes, the initial establishment of 
mid-gut infection and invasion of the proventriculus is much the same in T. congolense and T. 
brucei. 
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However, the developmental pathways subsequently diverge, with production of infective 
metacyclics in the proboscis for T. congolense and in the salivary glands for T. brucei (Peacock et 
al., 2012) (Figure 1.1). Coustou et al. (2010) recently devised a complete in-vitro life cycle model 
of T. congolense which offers the opportunity to perform functional genomics analysis like RNA 
interference (RNAi) throughout the whole life cycle.   
 
1.4 Pathology and pathogenesis  
Most trypanosomatid parasites including T. congolense have both arthropod and mammalian 
hosts. In addition, the ability to survive and complete a developmental cycle in each of these 
very different environments is essential for life cycle progression and hence for being a 
successful pathogen. For African trypanosomes, where the mammalian stage is exclusively 
extracellular, this presents specific challenges and requires evasion of both the acquired and 
innate immune systems, together with adaptation to a specific nutritional environment and 
resistance to mechanical and biochemical stresses (Gadelha et al., 2011).  
 
Following the successful feeding of an infected tsetse fly, metacyclic trypanosomes become 
established in the skin. Initial replication of trypanosomes is at the site of inoculation in the 
skin; this causes a swelling or chancre (FAO, 1998). Local skin reaction can develop in human as 
well as domestic animals. Trypanosomes then spread via draining lymphatics to the lymph 
nodes and blood and continue to replicate. During the acute phase of trypanosomosis, changes 
in vascular bed are the most striking. These changes in vascular bed include thrombi formation, 
thrombocytopenia, vasculitis in varying degrees and formation of vasoactive substances. 
Antibodies elicited by the glycoprotein coat of the trypanosome kill the trypanosome and result 
in the development of immune complexes.  
Ch
ap
te
r 1
  7  
 
Fi
gu
re
 1
.1
 L
ife
 c
yc
le
 o
f t
ry
pa
no
so
m
e.
  
a)
 D
ua
l 
cy
cl
e 
be
tw
ee
n 
th
e 
 t
se
ts
e 
fly
, 
hu
m
an
s 
an
d 
an
im
al
 r
es
er
vo
irs
. 
Th
e 
an
im
al
 r
es
er
vo
irs
 e
nc
om
pa
ss
 b
ot
h 
sy
lv
at
ic
 (
na
tiv
e 
w
ild
 a
nd
 
do
m
es
tic
at
ed
 a
gr
ic
ul
tu
ra
l 
an
im
al
s, 
pr
ov
id
in
g 
a 
do
ub
le
 c
ha
lle
ng
e 
to
 c
on
tr
ol
. 
b)
 S
im
pl
ifi
ed
 l
ife
 c
yc
le
 e
m
ph
as
izi
ng
 t
he
 a
lte
ra
tio
n 
be
tw
ee
n 
am
pl
ifi
ca
tio
n 
an
d 
di
ffe
re
nt
ia
tio
n.
 In
fe
ct
ed
 m
am
m
al
s 
ha
rb
ou
r h
ig
h 
nu
m
be
rs
 o
f d
iv
id
in
g 
lo
ng
 s
le
nd
er
 fo
rm
s 
of
 th
e 
pa
ra
sit
es
 in
 t
he
ir 
bl
oo
ds
tr
ea
m
 
an
d 
tis
su
e 
sp
ac
es
. L
on
g 
sle
nd
er
 fo
rm
s 
di
ffe
re
nt
ia
te
 to
 a
 s
ho
rt
 s
tu
m
py
 fo
rm
, w
hi
ch
 is
 p
re
-a
da
pt
ed
 to
 th
e 
in
se
ct
 v
ec
to
r a
nd
 is
 g
ro
w
th
 a
rr
es
te
d.
 A
t 
so
m
e 
po
in
t 
in
va
sio
n 
of
 t
he
 c
en
tr
al
 n
er
vo
us
 s
ys
te
m
 (C
N
S)
 o
cc
ur
s,
 w
ith
 s
er
io
us
 c
lin
ic
al
 im
pl
ic
at
io
ns
. T
ra
ns
fe
r 
of
 t
he
 s
ho
rt
 s
tu
m
py
 f
or
m
 t
o 
th
e 
in
se
ct
 v
ec
to
r i
n 
a 
bl
oo
d 
m
ea
l i
s 
ac
co
m
pa
ni
ed
 b
y 
ra
pi
d 
di
ffe
re
nt
ia
tio
n 
to
 th
e 
pr
oc
yc
lic
 fo
rm
, w
hi
ch
 re
-e
nt
er
 th
e 
ce
ll 
cy
cl
e.
 M
ul
tip
le
 d
iff
er
en
tia
tio
n 
st
ag
es
, 
w
ith
 a
 n
on
-o
bl
ig
at
or
y 
m
ei
ot
ic
 a
nd
 s
ex
ua
l 
ph
as
e,
 a
re
 r
eq
ui
re
d 
to
 g
en
er
at
e 
th
e 
m
am
m
al
ia
n 
in
fe
ct
iv
e 
m
et
ac
yc
lic
 f
or
m
s 
(n
ot
 s
ho
w
n)
. 
M
et
ac
yc
lic
 fo
rm
s r
es
id
e 
in
 th
e 
sa
liv
ar
y 
gl
an
ds
 a
nd
 a
re
 a
lso
 g
ro
w
th
 a
rr
es
te
d.
 T
ra
ns
fe
r o
f t
he
se
 p
ar
as
ite
s b
ac
k 
to
 a
 m
am
m
al
ia
n 
ho
st
 d
ur
in
g 
fe
ed
in
g 
co
m
pl
et
es
 th
e 
lif
e 
cy
cl
e.
 A
da
pt
ed
 fr
om
 F
ie
ld
 a
nd
 C
ar
rin
gt
on
 (2
00
9)
. 
Chapter 1  
8 
 
Inflammatory processes occur in various organs with meningitis as the first lesion in the central 
nervous system, which can gradually result in meningo-encephalitis. Other organs which can be 
involved during trypanosomosis are the eye, endocrine organs and pituitary gland which can 
lead to severe hormonal imbalances in human and animals of both sexes (Zwart, 1989). In 
calves experimentally infected with T. congolense the most significant findings were 
enlargement of the liver, kidneys and spleen and increased volume of hematopoietic marrow at 
postmortem examination (Valli et al., 1978). Anaemia in human and animals is of major clinical 
importance in trypanosomosis. Moreover, glomerulonephritis and immunosuppression have 
been well documented in the pathogenesis of trypanosomosis. Immunologic lesions are 
significant in trypanosomosis and it has been suggested that many of the lesions in these 
diseases may be the result of the deposition of immune complexes that interfere with or 
prevent, normal organ function (Zwart, 1989).  
 
1.5 Clinical signs of  trypanosome infections 
Most cases of trypanosomosis are chronic, but acute disease, which may be fatal within a week, 
can also occur. The first sign of trypanosomosis may be a localized swelling (chancre) at the site 
of the fly bite, but this usually remains unnoticed. The primary clinical signs are intermittent 
fever, signs of anemia, lymphadenopathy and weight loss. Animals lose condition and become 
progressively emaciated. Milk yield may be decreased in dairy animals. Neurological signs, 
dependent edema, cardiac lesions, diarrhea, keratitis, lacrimation, appetite loss and other 
clinical signs have also been reported. Effects on reproduction include abortions, premature 
births and perinatal losses, as well as testicular damage in males. Deaths could be possible 
among untreated chronically infected animals and animals that recover clinically may relapse 
when stressed. Sudden deaths have been reported in small ruminants infected with T. vivax. 
Trypanosomes can cause immunosuppression and concurrent infections may complicate the 
disease (CFSPH, 2009).  
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1.6 Epidemiology  
1.6.1 Hosts 
The tsetse fly is unique to the African continent and transmits a parasite harmful to humans 
and lethal to livestock (Alsan, 2013). The Tsetse fly (Glossina) is the biological vector and wild 
animals are natural hosts. Wild animals susceptible to trypanosome infection include deer, 
antelope, African buffalo, wild Equidae, lions, leopards, warthogs, elephants, nonhuman 
primates and various rodents (CFSPH, 2009). Domestic animals are incidental hosts and cattle 
are the most important economically. However, anthropogenic changes (e.g. clearing of 
vegetation for settlements and agriculture, habitat fragmentation) can alter the interaction 
between the host, the parasite and the vector (Van den Bossche et al., 2010). In humans the 
disease is termed sleeping sickness and is caused by T. brucei gambiense and T. brucei 
rhodesiense. The animal trypanosomes very rarely cause human infection, but they do share 
animal reservoirs (wild and domestic) and tsetse vectors (OIE, 2013b). However, Wissmann et 
al. (2014) reported an association between the presence of HAT in a village and infection of 
cattle village with human infective parasites. In Tanzania, Hamill et al. (2013) documented pigs 
carrying the human infective sub-species T. b. rhodesiense using PCR based method. 
Furthermore, Desquesnes et al. (2013a) reviewed zoonotic aspects of T. evansi.     
 
1.6.2 Transmission of trypanosome infection  
Cyclical transmission: trypanosomes are transmitted through the bite of an infected tsetse fly. 
Tsetse flies get the infection when feeding on an infected animal; after implementation of the 
parasitic cycle during which the trypanosomes actively multiply in the fly (15–21 days) it 
becomes infective and may remain infective for the rest of its life (FAO, 1983). Transmission 
occurs in the early stage of the blood feeding, when the fly injects some saliva before sucking 
the blood of its host (CFSPH, 2009). This form of transmission occurs with T congolense, T. 
vivax, T. simiae, T. brucei and the trypanosomes responsible for human sleeping sickness, T. 
brucei gambiense and T. brucei rhodesiense (Morlais et al., 1998). Glossina spp. are strictly 
blood feeders living exclusively in tropical Africa. There are about thirty species or subspecies, 
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classified in three groups: palpalis, morsitans and fusca. Each species has distinct biological 
characteristics, but in general it may be said that the palpalis group consists basically of the 
species living in forest galleries or in the marginal areas of forests; the fusca group consists of 
large-sized species whose habitat is generally associated with equatorial forests; and the 
morsitans group consists mainly of species living in wooded savanna (FAO, 1983; Rogers and 
Randolph, 1993). 
 
Mechanical transmission: Biting flies, especially tabanids and stomoxes, but possibly other 
biting insects (including tsetse flies) are the mechanical vectors of T. vivax, T. congolense and T. 
evansi. Mechanical transmission can occur when interrupted feeding is re-started on a new 
host; thus it is efficient inside a group of animals but has little chance to occur at distance. 
Transmission of trypanosomes is effected provided that the interval between the two meals is 
short (Desquesnes and Dia, 2003; FAO, 1983). Vertical transmission can occur intra-utero and 
during partum. For T. evansi, contamination of wound and iatrogenic transmission caused by 
use of non-sterile surgical instruments could spread the disease (Desquesnes et al., 2013a).  
 
1.7 Occurrence of the disease  
African animal trypanosomosis occurs where the tsetse fly vector exists in Africa, between 
latitude 15°N and 29°S. T. vivax can also be transmitted mechanically by biting flies and thus is 
also found in parts of Africa free or cleared of tsetse and parts of Central and South America 
(CFSPH, 2009). T. evansi is found in Africa only in the Saharan and Sahelian regions where it is 
primarily a camel parasite, but it may be a parasite of horses, cattle and dogs as well. It also 
occurs in Asia, where it commonly causes disease in camels and horses. In Central and South 
America, it causes disease less commonly in cattle, water buffaloes, elephants and dogs. Thus it 
has a very wide distribution (Desquesnes et al., 2013b; FAO, 1983). 
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1.8 Development activities versus tsetse and trypanosomes dynamics  
The distribution and incidence of vector-borne diseases are affected by complex interactions 
between pathogen(s), vector(s) and host(s). In addition to genetic and phenotypic interactions 
between these factors, the population of vectors and hosts are also modulated by local 
environmental factors that can substantially affect their dynamics and influence disease 
transmission patterns and disease impact (Van den Bossche et al., 2010). Furthermore, changes 
in land cover and land use can also have a direct or indirect impact on the biodiversity of hosts 
and vectors and on the various interfaces between vectors and hosts including wildlife, 
livestock and humans (Reid et al., 2000; Van den Bossche et al., 2010). Briefly, anthropogenic 
land use changes can cause infectious disease outbreaks and re-emergence of the disease, and 
also modify the transmission dynamics in endemic regions. These changes include agricultural 
encroachment, deforestation, road construction, dam building, irrigation, wetland modification, 
mining, the concentration or expansion of urban environments and coastal zone degradation. 
Such changes in turn cause a cascade of factors that exacerbate the infectious disease burden 
(Patz et al., 2004). 
 
Countries in East Africa in an early stage of development depend heavily on the agricultural 
sector for the increase in employment, foreign exchange, government revenue and food (Lele, 
1989). Thus, the continuous development pattern in East Africa directly and/or indirectly 
affects trypanosomosis dynamics in many ways. Massive activities in the area of agricultural 
land expansion and development of infrastructures like road and residence are all happening at 
the expense of environmental destruction. Population growth, loss of herding lands to farmers, 
ranchers, game parks and urban growth, increased commoditization of the livestock economy, 
out-migration by poor pastoralists and dislocations brought about by drought, famine and civil 
war are increasing throughout East Africa. These problems are intensified as international 
development programs encourage privatization and individualization of formerly communally 
held resources (Fratkin, 2001). 
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Habitat fragmentation is one repercussion of development activities in individual countries and  
across the region. It has been indicated that habitat loss has a pervasive and disruptive impact 
on biodiversity in habitat remnants. The magnitude of the ecological impacts of habitat loss can 
be exacerbated by the spatial arrangement or fragmentation of the remaining habitat. 
Fragmentation in se is a landscape-level phenomenon in which species that survive in habitat 
remnants are confronted with a modified environment of reduced area, increased isolation and 
novel ecological boundaries. The implications of this on individual organisms are many and 
various, because species with differing life history strategies are differentially affected by 
habitat fragmentation (Ewers and Didham, 2006). Changes in agriculture, destruction of rain 
forest by building roads, clearing areas for commercial ventures further enhance peoples’ 
encounter with the vectors and other animals harboring trypanosomes thereby increasing the 
rate of transmission of the disease (Samdi et al., 2012). In eastern Zambia Ducheyne et al. 
(2009) reported that heavily fragmented areas have lower numbers of tsetse flies, but when the 
fragmentation of natural vegetation decreased, the number of tsetse flies increased following a 
sigmoidal-like curve. In another study in Panama, Cottontail et al. (2009) stated that 
anthropogenic influence on ecosystems such as habitat fragmentation has impact on species 
diversity and interactions. In their study trypanosome prevalence was significantly higher in 
bats from forest fragments, than in bats captured in continuous forest. 
 
Fly habitat reduction by anthropogenic factors is sometimes found in situations where pressure 
on land use is high (Mattioli et al., 2004). For instance, gradual encroachment of people and 
their livestock into inhabited areas and the subsequent alteration of the landscapes have been 
explained to be the major drivers of change in the development of an endemic livestock 
trypanosomosis situation (Van den Bossche et al., 2010). However, even in these scenarios 
tsetse encroachment often continues to curtail crop-livestock integration. This has been 
particularly the case for riverine tsetse fly species that often are able to become peri-domestic 
and accept irrigation schemes as new habitat and change host preference from reptiles to 
livestock and man (Mattioli et al., 2004). Because of this increasing host and reservoir role of 
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livestock, parasite transmission is gradually changing from a dominant ‘sylvatic’ to a dominant 
‘domestic’ cycle (Van den Bossche et al., 2010). 
 
1.9 Current trypanosomosis situation in Ethiopia  
Trypanosomosis in cattle, locally referred as "Gendi", is a serious constraint to livestock in areas 
of northwest and southwest Ethiopia at an altitude of below 2000 meters above sea level  
(m.a.s.l.) (Getachew, 2005). This disease has been reported in different animals from different 
parts of Ethiopia. For instance, typanosomosis prevalence was 6.3% in donkeys from Assosa and 
Homosha districts in Benishangul Gumuz Regional state (Abebe and Wolde, 2010), 5.85% in 
cattle from Western region (Dinsa et al., 2013), 5.6% in small ruminants from Awi zone (Kebede 
et al., 2009), 12.42% in cattle from Metekel and Awi zones (Mekuria and Gadissa, 2011), 8.2% in 
cattle from East Gojam zone (Mihret and Mamo, 2007), 4.4% in cattle from two districts of 
Bench Maji zone (Tadesse and Tsegaye, 2010), 17.2% in cattle from Metekel district of 
Northwest Ethiopia (Afewerk et al., 2000) and 8.57% in cattle from three districts of Western 
Oromia (Tasew and Duguma, 2012). 
 
1.10 Diagnostic methods 
The incubation period is 1-4 weeks and the disease in cattle usually has a chronic course with 
possible mortality, especially if there is poor nutrition or other stress factors (Aiello and Moses, 
2012). There are a number of techniques available for the diagnosis of animal trypanosomosis 
and each has its own limitations and advantages. The diagnosis is made through laboratory 
methods, because the clinical features of infection are not sufficiently specific (CDC, 2012).  
 
1.10.1 Clinical diagnosis  
The clinical signs of disease caused by these organisms vary, depending on the trypanosome 
species, the virulence of the particular isolate, age, and the species of host infected (Aiello and 
Moses, 2012; FAO/IAEA, 1993). The disease is classically acute or chronic and is affected by 
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poor nutrition, concurrent diseases and other stressors. Some animals may slowly recover but 
usually relapse when stressed for example by work, pregnancy, milking or adverse 
environmental conditions (FAO/IAEA, 1993). Thus, trypanosomosis is generally a chronic 
evolving disease which could be fatal if appropriate treatment is not established. The most 
important clinical sign is non-regenerative anaemia which is the most common why reason 
animals are unable to function normally. The major clinical signs are: intermittent fever, 
anaemia, oedema, lacrimation, enlarged lymph nodes, abortion, decreased fertility, loss of 
appetite, body condition and productivity, early death in acute forms, emaciation and eventual 
death in chronic forms often after digestive and/or nervous signs (Eisler et al., 2004; FAO, 1983; 
Getachew, 2005).  
 
1.10.2 Post-mortem lesions  
Necropsy findings vary and are non-specific (Aiello and Moses, 2012; CFSPH, 2009).  Acute cases 
are usually related to anaemia and prolonged antigen-antibody response: emaciation and 
serous atrophy of fat, enlarged lymph nodes, liver and spleen, excessive fluid in the body 
cavities and subcutaneous oedema and petechial haemorrhages. In chronic cases, lymphoid 
tissue may be atrophic or swollen with serous atrophy of fat and anemia. In the terminal 
phases, severe myocarditis is common as the animal is too debilitated to mount an immune 
response (Aiello and Moses, 2012; CFSPH, 2009).    
 
1.10.3 Laboratory diagnosis  
The choice of which test to use for the diagnosis of trypanosomosis depends first of all on the 
level at which the test is to be used (farmer, veterinary diagnostic laboratory, research 
institute) and the purpose for which the results obtained will be used (FAO/IAEA, 1993). 
Definitive diagnosis of the disease is dependent on the detection of the trypanosome in blood 
samples (Getachew, 2005). The more accurate the diagnosis of infections can be, the more 
targeted interventions can become and the greater the reduction in the risk of human disease. 
Selective treatment of infected animals in this way results in a holistic approach to disease 
Chapter 1  
15 
 
control, concurrently combating livestock and human disease agents and resulting in an overall 
improvement in the livestock and human health of rural populations (Picozzi et al., 2002). 
 
1.10.4 Parasitological methods  
The diagnosis is based on finding the parasite in body fluid or tissue by microscopy (CDC, 2012). 
Parasitological tests such as wet blood smears, Giemsa stained thin and thick blood smears, the 
micro haematocrit centrifuge technique (Woo method) (Woo, 1970), the buffy coat 
darkground-phase contrast technique (Murray et al., 1977) and miniature-anion exchange 
centrifugation technique (Lumsden et al., 1977) can be used to confirm a clinical diagnosis by 
demonstrating the presence of trypanosomes. Freshly collected blood can also be inoculated 
into laboratory mice which can then be examined for periods of up to 30 to 60 days to 
determine if trypanosome infections develop in them (FAO/IAEA, 1993).  
 
The examination of wet blood films and Giemsa stained thick and thin fixed blood films with the 
aid of the light microscope have been used as diagnostic methods ever since they were first 
used to identify the aetiological agents of trypanosomosis. In wet preparations, a drop of fresh 
blood is placed on a slide and covered with a glass slip. The slide is examined under a 
microscope and the trypanosome species is determined by the type of movement they produce 
among the erythrocytes. The detection limit of this technique is 8.3x103 trypanosomes per ml 
of blood (Eisler et al., 2004; Getachew, 2005; Paris et al., 1982).   
 
The microhaematocrit centrifuge technique (HCT), about 70μl of blood is collected in a 
microhaematocrit capillary tube and sealed on one end. The capillary tube is centrifuged at 
15,000 rpm for 5 minutes to concentrate the trypanosomes in the buffy coat layer. Then, the 
capillary tube is placed in a Woo viewing chamber and a cover slip of 24x24 mm is placed on 
the capillary tube. The space between the tubes and the cover slip is filled with a drop of water 
to reduce light diffraction. The buffy-coat plasma junction is examined for the presence of 
trypanosomes and species is identified through the type of their motility. The detection limit of 
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this technique is 5.2x102 trypanosomes per ml of blood (Eisler et al., 2004; Paris et al., 1982; 
Woo, 1970).  
 
Each test has been reported to have its own merits and demerits. According to Marcotty et al. 
(2008), the buffy coat method fails to detect 66% of the infected animals despite the 
sometimes high concentration of the parasite. However, in the absence of other diseases 
causing anaemia in individual animals, the findings of their study also indicated that the PCV-
value of an individual animal is a good indicator of the presence of a trypanosomes infection. 
Hence, in the absence of other factors causing anaemia, the use of PCV and its parallel 
combination with the parasitological diagnosis could improve the detection of trypanosome-
infected animals and ease the decision to treat them with a trypanocidal drug (Marcotty et al., 
2008). 
 
1.10.5 Serological tests 
Most serological tests offer an increased diagnostic sensitivity and specificity. Such tests are 
either capable of detecting anti-trypanosome antibodies, such as the indirect fluorescent 
antibody test (IFAT) and the antibody-detection enzyme-linked immunosorbent assay (Ab-
ELISA), or capable of detecting antigen fractions of the parasites (Ag-ELISA) (Eisler et al., 2004; 
FAO/IAEA, 1993). However, serological tests have no use in the early stages of an infection, 
before the rise of specific antibodies. There is thus a need for simple tools that improve the 
sensitivity of the parasitological diagnosis, particularly in chronic clinical cases and hence 
support the management of trypanosomosis (Marcotty et al., 2008). Serological tests based on 
antibody detection cannot differentiate between an active and a cured infection. 
 
1.10.6 Molecular Tests  
Diagnostic problems could be resolved by using molecular diagnostic tests though it has 
limitations such as the need for sophisticated and expensive infrastructure, and results become 
available only after a considerable delay (Eisler et al., 2004; Marcotty et al., 2008). However, 
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DNA based methodologies have been in use in different parts of the world for diagnosis of 
diseases (Picozzi et al., 2002). Detection of trypanosome DNA by PCR has resulted in a 
considerable improvement of species-specificity in the diagnosis of these parasites, in particular 
when compared to parasitological examination, which is limited in its specificity to the sub-
genus level. In addition, it has increased the sensitivity of diagnosis which is generally two to 
three times higher than direct parasitological techniques (Desquesnes and Dávila, 2002; 
Desquesnes et al., 2001). 
 
Rudramurthy et al. (2013) developed an invariant surface glycoprotein-75 (ISG-75)  gene based 
PCR assay that amplifies a 407 base pairs (bp) product specifically from the different T. evansi 
isolates. Cox et al. (2005) reported a PCR technique that targets the gene encoding the small 
ribosomal subunit in order to identify and differentiate all clinically important African 
trypanosome species and some subspecies. Desquesnes et al. (2001) successfully used a single 
PCR based on internal transcribed spacer 1 (ITS-1) of rDNA for detection and identification of 
Trypanosoma of African livestock including T. congolense types.  Furthermore, Geysen et al. 
(2003) developed a semi-nested PCR-RFLP approach using 18S small sub-unit ribosomal (Ssu-
rDNA) gene amplification as an easy method for species-specific diagnosis of Trypanosoma 
species in cattle. Recently, Trypanosoma vivax specific PCR based on T. vivax proline recemase 
(TvPRAC) gene was developed and proved to be specific for T. vivax, irrespective of its 
geographical origin. However, its analytical sensitivity was reported to be lower than that of 
ITS-1 PCR (Fikru et al., 2014).   
 
DNA techniques provide tests with high sensitivity to such a level that one single trypanosome 
can be detected in samples of whole blood. Nevertheless, microscopy remains useful 
particularly as it can be carried out directly in the field level and gives immediate results. The 
original molecular protocols were not immediately applicable to conditions in the field, due to 
the amount of processing required and the time involved prior to the testing of the samples 
themselves. However, developments in methods of extracting and/or preserving DNA have 
changed this, making sample collection with a view to diagnosis by PCR at the field level more 
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realistic (Picozzi et al., 2002). For instance, easy collection, storage or transfer of blood spots or 
buffy coats on filter paper has been successfully used for PCR-RFLP detection of T. congolense 
(Vitouley et al., 2011).   
 
1.11 Treatment of trypanosomosis 
It has been indicated that in the absence of an effective vaccine, the control of trypanosomosis 
has to depend on the use of trypanocidal drugs, trypanotolerant breeds of livestock, tsetse 
traps and insecticides (Holmes, 1997). However, the use of trypanocidal drugs to treat 
trypanosomosis in livestock has been and still is the main approach in controlling this disease in 
most African countries. The method is complicated by the fact that the efficacy of the currently 
available drugs is diminishing fast in some areas due to the development of drug resistance 
(FAO/IAEA, 1993; Holmes et al., 2004).  
 
Since 1938, the date of the discovery of the trypanocidal properties of the phenanthridines, 
trypanocidal drugs remained popular with farmers because they allow treatment of individual 
animals, they are relatively cheap and commonly available. Reports indicate that approximately 
35 million doses of trypanocidal treatments are used each year in Africa (Geerts and Holmes, 
1998; Holmes and Tort, 1988). Currently available trypanocidal drugs for use in domestic 
livestock are: homidium salts (Ethidium-Novidium), diminazene aceturate (Berenil), 
isometamidium (Samorin, Trypamidium) (Aiello and Moses, 2012; FAO, 1983; Geerts et al., 
2001; Holmes et al., 2004), quinapyramine sulfate (Antrycide), suramin sodium (Aiello and 
Moses, 2012; FAO, 1983) and melarsomine (Cymelarsan) (Holmes et al., 2004). The use of 
quinapyramine in cattle is discontinued due to its capacity to induce multi-drug resistance 
(Holmes et al., 2004). Livestock farmers in Ghibe valley most commonly use the trypanocidal 
drugs DA (Diminazene aceturate) and ISM (Isometamidium chloride) of diverse brands to 
control trypanosomosis in almost all sick animals without any clinical examination. 
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Against this widespread use of chemotherapy for control of trypanosomosis, trypanocidal drug 
resistance has been reported from different parts of Ethiopia. Multiple drug resistant T. 
congolense populations to DA and ISM were reported in naturally infected cattle of Metekel 
district (Afewerk et al., 2000). T. congolense populations resistant to diminazene aceturate 
(Berenil®), isometamidium chloride (Samorin®) and homidium chloride (Novidium®) were also 
reported in cattle from Ghibe (Mulugeta et al., 1997). T. congolense isolates resistant to DA and 
ISM were found in Ghibe, Bedelle and Sodo (Chaka and Abebe, 2003). Tewelde et al. (2004) 
reported isometamidium resistance in cattle from upper Didessa valley of western Ethiopia.  All 
of these reports employed either a mice experiment model or block treatment in field 
conditions for the diagnosis of trypanocidal drug resistance.  
 
1.12 Prevention and control of trypanosomosis 
Control and prevention of trypanosomosis involves different techniques in different parts of the 
world. The selection of techniques and the sequence in which they should be applied, however, 
depends on the prevailing conditions. Some of these conditions include the size of the area, 
tsetse distribution patterns and abundance, tsetse vulnerability, livestock systems, agricultural 
practices, livestock breeds, availability of infrastructure and capacity; availability of and access 
to intervention technologies and market demands and trade opportunities (Ilemobade, 2009).  
 
1.12.1 Sanitary prophylaxis  
African Animal Trypanosomosis (AAT) can be controlled by reducing or eliminating tsetse fly 
populations by traps, insecticides applied directly on the animal as a spray or pour-on (CFSPH, 
2009). The sterile male technique does not require insecticide and is environmentally benign 
(Allsopp, 2001). This technique is potentially valuable since females mate only once in a lifetime 
but production facilities are expensive and can only be applied at the end of the eradication 
campaign, when the density of remaining flies is very low. In addition, good husbandry of 
animals at risk and avoiding contact with tsetse flies as much as possible are common practices. 
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Introduction and selection of trypanotolerant breeds like the N’Dama and West African 
Shorthorn are also advocated (OIE, 2013b).  
 
1.12.2 Chemoprophylaxis  
Trypanocidal drugs are a widespread method of control in most African countries. However 
only three drugs are available for use against tsetse transmitted trypanosomosis, principally in 
cattle. They are diminazene, isometamidium and homidium (Holmes, 1997). Isometamidium 
chloride can be used as both curative and prophylactic drug whereas diminazene aceturate as 
curative. In addition, quinapyramine sulphate and chloride are available on market, but should 
not be used in ruminants as it causes cross-resistance to all available trypanocidal drugs (Geerts 
and Holmes, 1998). Chemoresistance may occur and care must be taken due to the presence of 
fake drugs on some markets. No vaccines are available nor likely to be there in the near future 
because of the ability of trypanosomes to rapidly change variable surface glycoproteins (VSG) in 
their coats to avoid an effective Immune response (antigenic variation) (Davila et al., 2003).  
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Ghibe/Omo is one of the major river basins in Ethiopia. The Ghibe River flows in a southerly 
direction in this valley and is a tributary of the Omo River, flowing into Lake Turkana on the 
Ethiopia/ Kenya border. The valley base lies at an altitude of approximately 1100 m (Leak et al., 
1996). In and around the valley a significant number of farmers make their living by a mixed 
crop-livestock production system. Trypanosomosis and land use are closely inter-related 
(Holmes, 1997). Evidently in trypanosomosis endemic areas like Ghibe, the most important 
indirect impact of trypanosomosis on crop production is through the availability and health of 
animals that provide animal traction. Because additional traction capacity allows farmers to 
expand the area that they cultivate, they can thus increase yields of existing crops, grow a 
different mix of crops or allocate labour, land and fertilizer more efficiently. Obviously, without 
effective drug therapy, the incidence of trypanosomosis increases and can thus devastate herds 
of trypano-susceptible cattle and the farming systems in which those cattle are integrated 
(Swallow, 1999). 
 
Tsetse and trypanosomosis research and intervention in Ghibe Valley of South-western Ethiopia 
has started long time back (Codjia et al., 1993; Leak et al., 1996; Rowlands et al., 1999) and yet 
the disease continues to have an impact on both the agricultural and animal production 
sectors. In this regard, the development of drug resistance takes the lion's share among factors 
contributing to reduced efficiency of ongoing control and prevention programs because control 
and prevention has been almost entirely dependent on chemotherapy and chemoprophylaxis. 
In view of today’s trypanocidal drug resistance reports from various parts of the tsetse belt in 
Ethiopia, there is an urgent need for an in-depth study of trypanocidal drug resistance 
development. Furthermore, resistant T. congolense strains circulating in indigenous cattle 
should be characterized. Insights in the resistance pattern in Ghibe river basin of Ethiopia are 
required; this will be helpful to formulate effective intervention protocols to be applied on a 
large scale.  
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General objective 
The general objective of this PhD dissertation is to assess the magnitude of T. congolense 
trypanocidal drug resistance using different tests and survey the perception of drug use by 
farmers in Ghibe valley of Ethiopia.  
 
Specific objectives 
This study was undertaken for the following specific objectives: 
 i. To review literature on trypanocidal drug resistance in east African countries mainly 
Ethiopia, Kenya, Uganda and Tanzania (Chapter 2). 
 ii. To assess the occurrence of DA and ISM resistance on T. congolense isolates using a 
mice-based experimental model and to compare it with a PCR-RFLP method (Chapter 3).  
 iii. To compare the conventional haematocrit centrifugation technique with PCR on 
 different sample storage conditions (Chapter 4).   
iv. To study T. congolense infection dynamics over a period of 6 months (longitudinal 
study) in high prevalence areas of Ghibe valley using microsatellite markers in light of 
drug resistance (Chapter 5).  
v. To conduct a questionnaire survey that generates information on knowledge, attitude 
and practice of livestock owners towards trypanocidal drug use (Chapter 5).   
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2.1 Background and justification  
Botswana, Ethiopia, Eritrea, Kenya, Malawi, Swaziland, Madagascar, Mozambique, Sudan, 
Tanzania, Uganda, Zambia and Zimbabwe form together East Africa (Figure 2.1). Arable areas in 
the region are under severe pressure to increase their productivity in order to feed a rapidly 
increasing human population (IFPRI, 2013). In fact the potential for increasing livestock 
production can only be fully realized if the animals are adequately protected against the 
adverse effects of periodic stresses and diseases (Samdi et al., 2010). 
 
Trypanosomosis in domestic livestock negatively impacts food production and economic 
growth in many parts of the world, particularly in sub-Saharan Africa (SSA) (Taylor, 1998). It has 
been said that a large proportion of the world’s poorest people struggles to exist in tsetse-
infested SSA (Allsopp, 2001) which encompass East Africa. In the tsetse-infested countries of 
East Africa, half of the population suffers from food insecurity. It has been documented that 
approximately 85% of the poor are located in rural areas out of which over 80% relies on 
agriculture for their livelihood (Mattioli et al., 2004). For obvious reasons, the agricultural 
segment in this region is dependent on animal traction power. 
 
Endemic animal diseases such as tsetse-transmitted trypanosomosis are a constant drain on the 
financial resources of African livestock keepers and on the productivity of their livestock (Shaw 
et al., 2014). African trypanosomosis is a disease complex unique to SSA, affecting both humans 
(sleeping sickness) and animals (nagana or African animal trypanosomosis (AAT). It is caused by 
a protozoan blood parasite, the trypanosome, and is transmitted by the tsetse fly (Glossina) 
which is confined to SSA (Ilemobade, 2009). The causative agent, the trypanosome, can be 
found wherever the tsetse fly vector exists. Tsetse flies have been reported to be endemic in 
Africa between latitude 15° N and 29° S, from the southern edge of the Sahara desert to 
Zimbabwe, Angola and Mozambique. 
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Figure 2.1 Map of East African countries. (Source: http://wikitravel.org/upload/shared//3/3f/ 
East_Africa_regions_map.png).  
 
Trypanosomes, particularly T. vivax, can spread beyond the “tsetse fly belt” by transmission 
through mechanical vectors such as Tabanus spp and other biting flies. For instance, T. vivax is 
found in South and Central America and in the Caribbean, areas free of the tsetse fly (Aiello and 
Moses, 2012; CFSPH, 2009). In Africa, the most important trypanosome species from both 
medical and veterinary point of view are those transmitted by tsetse flies of the African genus 
Glossina (FAO/IAEA, 1993). 
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African trypanosomosis has been considered as a re-emerging infection of epidemic proportion 
as the necessary control programs have not been maintained due to a variety of social, political 
and economic reasons. It has not been possible to use novel control tools in these  regions 
because of political unrest and economic constraints (Seed, 2001). Though Tsetse and 
Trypanosomosis (T and T) is one of the trans-boundary insect pest and disease problems that 
constitute a key bottleneck to sustainable agriculture and rural development (SARD) in SSA, 
including East Africa (Ilemobade, 2009), no strong regional collaboration exists to implement 
available control strategies. In addition, there are fragmented reports of trypanocidal drug 
resistance development in different areas across the region. Therefore the objective of this 
review paper is to discuss the situation of trypanocidal drug resistance in East African countries 
with emphasis on Ethiopia, Kenya, Uganda and Tanzania. 
 
2.2  Trypanocidal drugs and their use in East Africa 
Currently, only three trypanocides are available for controlling tsetse-transmitted 
trypanosomosis in domestic ruminants and these are isometamidium (ISM) and homidium, 
which have both prophylactic and therapeutic effects, and diminazene, which has only 
therapeutic properties (Geerts et al., 2001). Of these compounds, the most widely used 
therapeutic agent in cattle, sheep and goats is diminazene aceturate (DA). In camels, 
melarsomine is used for treatment of T. evansi infection (Holmes et al., 2004). Details of these 
trypanocidal drugs are summarized in Table 2.1.  
 
Diminazene was first described in 1955 (Peregrine and Mamman, 1993). In addition to its 
trypanolytic effects, recently it has been shown that it also modulates the host immune 
response by inhibiting key signaling molecules and transcription factors associated with pro-
inflammatory cytokine production (Kuriakose and Uzonna, 2014).  
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Diminazene aceturate is marketed a.o. under the trade names Azidine, Berenil, Ganaseg, 
Ganasegur and Veriben as both a trypanocide and babesiacide for domestic livestock (Peregrine 
and Mamman, 1993).  
 
Isometamidium (Samorin, Trypamidium) was introduced on the market in 1961 and little is 
known about its mechanism of action (Boibessot et al., 2006) except for its DNA intercalating 
properties (Wainwright, 2010) and thus mutagenic effects. Its main advantage is its 
effectiveness on trypanosomes resistant to other drugs. At the same time it has the 
disadvantage of easily creating drug-resistant strains itself; however, these trypanosomes show 
no cross-resistance with DA, which therefore retains its effectiveness on such strains. DA and 
ISM constitute a "sanative pair" which means that once resistance develops to one of the drugs, 
the other drug should be used to control the infection (Desquesnes et al., 2013). ISM can 
provide  up to 6 months protection against tsetse challenge. The ISM deposit at the injection 
site can cause a persistent local reaction which may be invisible from the outside if a deep 
intramuscular injection has been given, as is recommended (FAO, 1983).  
 
The appropriate use of the few available trypanocidal drugs is the coordinated effort of 
livestock owner, private and government bodies. All of them have their role to play in avoiding 
drug resistance, as is described below.  
 
2.2.1 The livestock owner 
Trypanocidal drugs are freely available in different shops of rural Africa and farmers have full 
access to get them for treatment of their animals. As there has been neither guideline nor 
awareness on when to use, to which animal, how much to use and how to administer, 
treatment failure is likely to occur in a high proportion of animals. The failure of drug treatment 
might have causes other than drug resistance such as significant under-dosing, treatment with 
sub-standard quality drugs, or rapid re-infection after treatment (Geerts et al., 2001). A study 
indicated that giving rational drug use information to farmers improved their knowledge and 
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management of trypanosomosis as well as the clinical outcome in cattle they treated and had 
no discernible negative impacts (Grace et al., 2008). 
 
2.2.2 The political level  
In the past, the availability of trypanocidal drugs was strictly controlled in most African 
countries by Government Veterinary Departments. However, in recent times, with the 
privatization of veterinary services and a general trend towards deregulation of markets, 
trypanocides, along with many other pharmaceutical products, have become more freely 
available through local pharmacists, agro-veterinary suppliers and the informal sector and 
many are now purchased directly by farmers (Geerts et al., 2001).  
 
In principle, government regulatory agencies have the important responsibility to ensure that 
only safe, effective, high-quality, well-manufactured and properly labeled animal drugs and 
biologicals are available on the market and that unsafe and ineffective products, such as 
counterfeit and illegally compounded medicines are not available on the market (Smith, 2013). 
Currently, however, no effective regulatory programs seem to be in place in East Africa. 
Because of this inefficient or absent regulatory program, trypanocidal drugs are misused by 
farmers and even paraprofessionals. It also paved the way for some illegal production units to 
flourish and produce counterfeit and substandard drugs. Counterfeit drugs are those that 
mimic authentic drugs; substandard drugs are those produced with little or no attention to 
good manufacturing practices (Pecoul et al., 1999). Treatment failure and drug-resistance are 
thought to be possible consequences of the use of substandard drugs (Shakoor et al., 1997).  
 
2.3 Trypanocidal drug resistance reports from various parts in East Africa 
The widespread and often unregulated use of currently available drugs, both as treatment and 
in prophylaxis, has inevitably led to the development of drug resistance (Geerts et al., 2001). 
Some cases of resistance were observed early in the use of DA. It was the accepted view at the 
time that this was the result of cross-resistance with quinapyramine and that DA did not 
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directly cause resistance because of its rapid elimination through the kidneys, which prevents 
accumulation of residual sub-curative doses. Since 1967, however, strains of trypanosomes 
directly resistant to DA have been found in various countries, notably in the Central African 
Republic, Chad, Kenya, Nigeria and Uganda, primarily with regard to T. vivax but also to T. 
congolense. These strains are fortunately still vulnerable to the phenanthridine group of 
trypanocides, particularly ISM, leading to the conclusion that in case of failure of a DA 
treatment it is preferable to use another trypanocide such as ISM rather than giving further 
treatment with an increased dose of DA (FAO, 1983). Various researchers across East Africa 
reported resistance to currently available trypanocidal drugs and the approaches to the 
mechanisms of drug resistance in trypanosomes have been extensively reviewed by Alsford et 
al. (2013) and Delespaux et al. (2008b).          
 
Drug resistant trypanosomes have been claimed to be less virulent. For instance, Egbe-Nwiyi et 
al. (2005) demonstrated that DA resistance appeared to reduce the virulence of T. brucei in 
naive rats used in their study. However, loss of fitness in drug resistant trypanosomes has not 
been a consistent finding from the limited number of studies that have been conducted 
(Holmes et al., 2004). This was never confirmed in cattle but would have important 
epidemiological repercussions in the field.  
 
2.3.1 Drug resistance in Ethiopia 
Trypanocidal drug resistance studies in different areas of Ethiopia used methods such as mice 
based tests (Afewerk et al., 2000; Chaka and Abebe, 2003; Codjia et al., 1993; Mulugeta et al., 
1997), tests in rats (Mulugeta et al., 1997), sensitivity tests in cattle (Afewerk et al., 2000; Chaka 
and Abebe, 2003; Codjia et al., 1993; Mulugeta et al., 1997; Tewelde et al., 2004) and test in 
goats (Codjia et al., 1993). Apart from these in vivo and field based techniques, Moti et al. 
(2012) reported high prevalence of DA resistance using the DpnII-PCR-RFLP (see further section 
3.5).  
 
Chapter 2 
44 
 
Chaka and Abebe (2003) reported that isolates of T. congolense from Ghibe, Bedelle and Sodo 
were resistant to a therapeutic dose of DA (3.5 mg/kg) and to a standard therapeutic and 
prophylactic doses of ISM (0.5 and 1 mg/kg). However, all three stocks were found to be 
sensitive to 7 mg/kg DA. The fourth, the Arba Minch stock, was reported resistant to the 
manufacturers’ recommended doses of DA and ISM.  
 
According to Codjia et al. (1993), 12 trypanosome isolates collected from cattle in Ghibe were 
reported to be resistant to 7.0 mg/kg, 0.5 mg/kg and 1.0 mg/kg body weight of diminazene, 
isometamidium and homidium chloride, respectively, except for one isolate which was sensitive 
to 0.5 mg/kg b.w. ISM. In another study, Mulugeta et al. (1997) indicated a long-term 
occurrence of T. congolense resistant isolates to diminazene, ISM and homidium at doses of 7.0 
mg/kg, 0.5 mg/kg and 1.0 mg/kg, respectively in cattle from Ghibe valley. Recently, Afewerk et 
al. (2000) showed the presence of multiple-drug-resistant T. congolense in village cattle of 
Metekel district, northwest Ethiopia. In addition, Tewelde et al. (2004) documented the 
presence of ISM resistance of trypanosomes infecting cattle in the upper Didessa valley and ISM 
resistant T. congolense has also been reported in naturally infected donkeys (Assefa and Abebe, 
2001). Moti et al. (2012) also reported T. congolense DA and ISM resistance using a mice model 
and DA resistance using DpnII-PCR-RFLP in the Ghibe valley of Ethiopia. Besides, there are 
reports of multiple drug resistance (Afewerk et al., 2000; Codjia et al., 1993; Mulugeta et al., 
1997; Tewelde et al., 2004) which need to be taken into consideration during control and 
prevention using drugs.  
 
2.3.2 Drug resistance in Tanzania 
Mbwambo et al. (1988) subjected cattle naturally infected with T. congolense to DA treatment 
and reported T. congolense refractory to treatment at 7.0 to 14.0 mg/kg at Kibaha, Tanzania. T. 
brucei rhodesiense strains isolated from sleeping sickness patients in Tanzania showed 
resistance to melarsoprol at 5 mg/kg and at 10 mg/kg; diminazene at both 14 and 28 mg/kg; 
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suramin at a dose of 5 mg/kg; ISM at 1.0 mg/kg and one isolate was cross-resistant to suramin 
and ISM (Kibona et al., 2006).  
 
2.3.3 Drug resistance in Kenya 
Multiple drug resistance was reported in T. congolense isolated from parasitaemic local Zebu 
cattle in Transmara District, Kenya, to therapeutic doses of both DA and ISM, 10 mg/kg and 1 
mg/kg, respectively (Mapenay and Maichamo, 2008). In another study, seven T. vivax isolates 
from Kenya and Somalia were found resistant to the recommended dose rates of ISM, 
homidium and quinapyramine but all were sensitive to DA (Schönefeld et al., 1987).  Field 
survey on drug use in Kwale district of Kenya documented cases of incorrect drug use and 
suggested this to be one of the reasons of drug resistance (Mugunieri and Murilla, 2003). Gray 
et al. (1993) used an in vitro assay to determine the drug sensitivity in T. congolense and 
reported high levels of resistance in KE 3302 and KE 3303 to ISM at doses of 100 ng/ml and 
1000 ng/ml, respectively at Nguruman, Kenya. 
 
2.3.4 Drug resistance in Uganda 
In Mukono County farms, eighteen trypanosome isolates were collected from cattle and were 
characterized in cattle, goats and mice for their sensitivity to homidium, ISM and diminazene. In 
this study, 4 populations were reported refractory to treatment with ISM at 0.5 mg/kg bw in at 
least 1 out of 3 goats each. Furthermore, 5 populations were documented refractory to 
treatment with homidium chloride at 1.0 mg/kg b.w. in a minimum of 2 out of 3 goats each 
(Olila et al., 2002). In vivo drug sensitivity study of Trypanosoma evansi isolates from camel in 
Moroto revealed relapses when half the recommended doses of Triquin-S® (quinapyramine 
sulphate) and Cymelarsan® (melarsenoxyde cysteamine) were used and Trypan® (diminazene 
aceturate) up to 14mg/kg was not able to clear the infection in mice (Kabi et al., 2009).  
 
As cross-resistance between currently available trypanocidal drugs has been reported in many 
countries in East Africa, which makes that the concept of sanative pairs may no longer work 
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(Getachew, 2005). These difficulties and the apparent impossibility to develop a vaccine and 
the logistical problems of restocking with the few trypanotolerant breeds of cattle, means that 
trypanosomosis is best tackled by controlling tsetse, with drugs as temporary expedients (Vale, 
2009). 
 
2.4 Socio-economic implication of drug resistance in East Africa  
AAT is a dynamic disease, both in space and time. The most important factor affecting the 
disease today is the rapidly expanding human population complicated by differing local 
situations (Ilemobade, 2009). The functions of livestock in Africa are multiple with their 
economic and social importance depending on the production system (FAO/IAEA, 1993). 
Domestic animals enhance the economic viability and sustainability of farming systems. They 
diversify production and management options, increase total farm production and income, 
provide year-round employment and provide insurance in times of need. Sales of livestock 
products provide funds for purchasing critically needed crop inputs and for financing farm 
investments. Livestock often forms the major capital reserve of farming households (FAO, 
1992). Since the socio-economic impact of AAT varies within and between countries, regions 
and agro-ecological zones, a proper appreciation of the causal relationship between poverty 
and tsetse related development constraints is crucial (Mattioli et al., 2004). The socio-economic 
implications of drug resistance development are also diverse and difficult to quantify.  
 
2.4.1 Crisis of professional enthusiasm  
Veterinary professionals diagnose sick animals and treat them accordingly. In this activity, one 
form of professional satisfaction is observing animals recovering because of the treatment that 
was administered. In contrast, a failure of the treatment because of conditions like drug 
resistance inevitably makes the clinician less confident in his day to day professional practice. 
This condition might even be more pronounced in the African context where most of the 
communities are poorly aware of good veterinary practices.  
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2.4.2 Livestock farmer and the farming system 
Clinical diagnosis of sick animals is mostly followed by the right treatment, but treatment failure 
is sometimes inevitable because of the presence of drug resistance in trypanosomosis endemic 
areas. If treated animals do not recover, livestock farmers are not motivated to present their 
animals to a veterinary "hospital" or clinic in the rural areas of East Africa. Broadly, because of 
resistance development, the use of chemotherapy and chemoprophylaxis is in question, thus  
so is the control of the disease. From the point of view of producers, livestock diseases 
including trypanosomosis are essentially an economic problem. Diseases that reduce 
production, productivity and profitability are associated with the cost of their treatment, 
disruption of local markets, international trade and exacerbate poverty on rural, local, and 
regional communities (Lammy et al., 2012). It can cause direct losses (deaths, stunting, reduced 
fertility, and changes in herd structure) and indirect losses (additional costs for drugs, added 
labor costs and profit losses due to denied access to better markets and use of suboptimal 
production technology) (Lammy et al., 2012; Rushton, 2009). Apart from the above direct 
economic loss, a vast area of arable land cannot be utilized for agricultural purposes due to the 
presence of trypanosomosis. In addition, trypanosomosis is also partially responsible for  the 
shortage of animal protein in the world (Dagnatchew, 1982). In terms of agricultural Gross 
Domestic Product (GDP) the total loss has been reported as US$ 4.75 billion per year in Africa 
(FAO, 2014).  
 
2.4.3 Impact on pharmaceutical industries 
All three drugs (ISM, DA, Homidium) have been on the market for more than 50 years and, for 
much of this time, they have been provided by a few European manufacturers (Geerts et al., 
2001). However, the absence of new and efficient veterinary drugs has contributed to the 
appearance of counterfeit drugs on the market in East Africa (Pecoul et al., 1999; WHO, 2012, 
2010) made by local companies that now compete with imported standard drugs from licensed 
companies. Obviously, this market competition discourages the few pharmaceutical industries 
to maintain the production and invest in the search for new drugs.  In addition, a lack of quality 
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control on production of generic forms of the drug contribute to treatment failure and 
development of drug resistance (Pecoul et al., 1999). 
 
2.5  Detection methods of trypanocidal drug resistance  
The trypanosomes infective to livestock in Africa have not been studied in detail at the 
molecular level as compared to those that are infective to humans (Delespaux et al., 2005). 
Several methods have been developed during recent years for the detection of drug resistance 
in trypanosomes. Most of the in vivo and in vitro assays for this purpose are better suited for 
the determination of drug resistance of a small number of isolates, than for large-scale 
screening (Gall et al., 2004).  
 
In vivo assays 
The most commonly used in vivo assays include tests in mice and ruminants (Eisler et al., 2001). 
Guidelines for standardized testing of trypanocidal drugs in vivo are well described in Eisler et 
al. (2001).   
 
The tests in mice are primarily applicable to those trypanosome species that are readily 
infective for mice, i.e. T. brucei and T. congolense. The single-dose test in mice has been 
conveniently used in areas with limited laboratory facilities and was found appropriate for the 
characterization of geographic areas in terms of trypanocidal drug resistance using a large 
number of trypanosome isolates compared to tests in cattle (Eisler et al., 2001). A group of six 
mice is required for each drug to be tested and an additional control group of 6 mice. ISM and 
DA should be used at the dose of 1.0 and 20.0 mg/Kg B.W., respectively. In contrast, a multi-
dose mice test requires at least 6 groups of six mice for each drug to be tested. The dose range 
varies between 0.01 and 20 mg/Kg B.W. for ISM and 1-60 mg/Kg B.W. for DA. After treatment, a 
parasitological examination of the mice should be conducted twice a week using phase-contrast 
microscopy of a wet smear of tail blood. The treated groups should be followed until relapse 
occurs or until 60 days post treatment (Eisler et al., 2001).   
Chapter 2 
49 
 
The tests in ruminants consist of infecting a group of cattle (mainly calves) or small ruminants 
with the isolate under investigation and to treat them with various dosages of trypanocide at 
the first appearance of parasites. The test in calves is mostly used for the investigation of drug 
resistance in T. vivax which is not usually infective for mice. Calves used should be about 3-6 
months old, of a genotype similar to the cattle in the area under study and without prior 
exposure to tsetse or trypanosomosis. It is advisable to use a minimum of three and preferably 
six animals per isolate and the animals must be kept in fly-proof accommodation or in a non-
tsetse area. The animals are regularly monitored over a period of 100 days to determine the 
efficacy of standard drug doses in terms of their ability to provide a permanent cure (Eisler et 
al., 2001; Holmes et al., 2004).  
 
The disadvantages of these in vivo assays are the requirement of a long duration of follow-up 
(60 days in mice and up to 100 days in cattle), curative doses in ruminants that cannot be fully 
extrapolated from the results in mice and the fact that T. vivax and some T. congolense strains 
do not grow in mice (Delespaux et al., 2008b; Eisler et al., 2000, 2001). The tests in ruminants 
are useful when laboratory facilities are limited, but they only allow the qualitative assessment 
of the inoculated isolate. Furthermore, it must be taking into account that not all populations of 
trypanosomes that are inoculated grow equally well (Holmes et al., 2004).  
 
In vitro assays 
An in vitro assay utilizes procyclic, metacyclic or bloodstream forms of trypanosomes for 
evaluation of drug sensitivity (Holmes et al., 2004). In another study, metacyclic forms have 
been used for sensitivity study  of ISM, DA and homidium salts at various drug concentrations 
(0.5 ng - 50 μg/ml). The results of this in vitro assay has been found well correlated with field 
observations (Gray et al., 1993). In vitro assays are expensive to perform and require good 
laboratory facilities and well-trained staff (Holmes et al., 2004). As an alternative to in vitro 
cultivation of bloodstream forms, Clausen et al. (1999) used a drug incubation Glossina 
infectivity test (DIGIT) to assess the susceptibility of T. congolense bloodstream forms to 
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trypanocidal drugs. Briefly, blood infected with T. congolense is incubated at 37°C for 30 
minutes and 12 hours, respectively, in the presence of different drug concentrations (0.5, 1,10 
and 100 μg/ml blood) of DA or ISM. After that, the trypanosome/blood/drug suspensions are 
fed to tsetse flies through an in vitro feeding system, using a silicon membrane. All tsetse flies 
are then dissected and examined for presence of trypanosomes in labrum, hypopharynx and 
midgut 20 days after their infective blood meals. This technique distinguish resistant from 
sensitive isolates and does not require experimental animals, but it does require a supply of 
teneral tsetse flies from an artificially reared colony (Holmes et al., 2004). In another study, 
Knoppe et al. (2006) used a drug incubation infectivity test (DIIT) to confirm all field stocks that 
were resistant to 1.0 mg/kg B.W. isometamidium in the standard mouse test (SMT). Briefly, 
non- immunosuppressed donor mice are infected with trypanosomes by intraperitoneal 
inoculation. Trypanosomes are harvested from anesthetized mice and separated from blood 
cells using DEAE cellulose. A sample of 0.5 ml of 1-2 x 105 viable trypanosomes per ml PSG, pH 
8.0 containing 20% goat sera are incubated in ISM concentrations 0, 0.5, 5, 50 or 500 ng/ml at 
35°C, 5% CO2 in air for 10 minutes in 24 well culture plates. The tests are carried out in five 
replicates. After incubation, 0.5 ml of each well's contents are injected intraperitoneally into 
one mouse each. Mice are screened three to five times per week using HCT for 30 days for 
trypanosome infections. When found positive on two consequetive days, mice are considered 
infected. Those in vitro techniques are not routinely used and no recent publication is reporting 
their use. 
 
Field observational method 
Longitudinal block treatment is an observational methods developed to overcome the 
expensive and time consuming constraints of both in-vivo and in-vitro tests. It is conducted 
without the need for isolation of trypanosomes under natural challenge in the field and 
appropriate for areas without laboratory facilities (Eisler et al., 2000, 2001). Cattle are 
randomized in a treatment and a sentinel groups. All animals are given a dose of 7 mg/Kg DA 
before the start of the experiment. The treatment group is given ISM at 1 mg/Kg B.W. and all 
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treatment and sentinel cattle are followed for presence of trypanosomes every two weeks 
using the phase-contrast buffy coat technique (Murray et al., 1977) over a three months period. 
If more than 25% of ISM treated cattle become infected within 8 weeks of exposure, this 
strongly leads to the suspicion of the occurrence of drug resistant trypanosomes (Eisler et al., 
2000). If less than 25% of the sentinel group is becoming positive, it indicates a low challenge of 
the disease. Prophylaxis is thus not advised in such a context. Mungube et al. (2012) are 
reporting a shorter and less labor intensive method of block treatment and the observation 
period is limited to 1 month. Alternatively to the block treatment methods, longitudinal 
parasitological data has been used to compare trypanosome incidence and prevalence in herds 
under therapeutic drug regimen, using PCV to distinguish new from recurrent infections 
(Holmes et al., 2004). Rowlands et al. (2001) described and used a method for calculating new 
infection incidence from monthly field data in cattle in southwest Ethiopia. In their study, an 
infection was defined as a new infection if it was preceded by two previous months in which 
both samples had a PCV ≥ 26% and were not detected with trypanosomes. This method 
requires a huge dataset covering a long period of time and is not used in practice. 
 
ISM-ELISA and the mitochondrial electrical potential 
ISM resistance can also be detected using an ELISA technique in which ISM serum concentration 
of at least 0.4 ng/ml with the concomitant presence of trypanosomes has been documented to 
suggest that the parasites are resistant (Delespaux et al., 2008b; Eisler et al., 1997). In another 
study, in a drug sensitive population of T. congolense, agents affecting mitochondrial function 
were shown to produce dose dependent inhibition of mitochondrial membrane potential, as 
measured by the accumulation of the lipophilic cations methyltriphenylphosphonium iodide or 
rhodamine 123. It was also reported that the agents produced parallel inhibition of 
isometamidium uptake, suggesting an involvement of mitochondrial membrane potential in the 
accumulation of the drug which could be used as a candidate marker for ISM sensitivity study 
(Delespaux et al., 2008b; Wilkes et al., 1997). This method has not been developed up to now 
(17 years later).  
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Molecular methods for detection of drug resistance  
A simple PCR-RFLP test for DA resistance detection was developed by means of the Single 
Strand Conformation Polymorphism technique (SSCP) based on a T. congolense gene (wrongly 
called TcoAT1) presenting a high blast similarity with the adenosine transporter 1 gene (TbAT1) 
of T. brucei coding for a P2 type nucleoside transporter (Delespaux et al., 2006).  Later on, this 
PCR-RFLP test’s ability to amplify low concentrations of DNA was enhanced by adding a step of 
whole genome amplification using the QIAGEN REPLI-g UltraFast Mini Kit. Its specificity was 
improved by replacing the BclI (T^GATCA) enzyme by DpnII (^GATC) (Vitouley et al., 2011). 
Recently this test was questioned by Munday et al. (2013),  who reported that the wrongly 
called TcoAT1 gene was coding for a P1 type purine nucleoside transporter (TcoNT10) that does 
not mediate DA uptake. Based on the available data, there was a 100% correlation between 
gold standard (test in mice) and the DpnII-PCR-RFLP (Moti et al., 2012). Delespaux and de 
Koning (2013) argue that due to this large correlation the test remains valid until additional 
experimental data further validate or invalidate it.  
 
Amplified fragment-length polymorphism (AFLP) was also used  for the study of ISM resistance 
in two isogenic clones of T. congolense differing in the level of resistance by a 96 fold factor 
(Delespaux et al., 2005). The procedure identified a gene coding for an 854 amino acid protein 
(presenting some signatures of an ABC (ATP binding cassette) transporter (Delespaux et al., 
2008a, 2005). A triplet insertion coding for an extra lysine has been found in the genes of the T. 
congolense resistant strains. The presence of the insertion was found to be consistently present 
in the genomes of the T. congolense clones that were resistant to ISM (Delespaux et al., 2005). 
However, this test was abandoned as the correlation was consistent with Zambian isolates but 
fell down to 30% with isolates from Burkina Faso (Delespaux personal communication). In 
another study, Afework et al. (2006) used PCR-RFLP based on the adenosine transporter-1 gene 
in T. brucei (TbAT1), encoding a P2-type nucleoside transporter, from T. brucei brucei field 
stocks to investigate a possible link between the presence of mutations in this gene and ISM 
resistance. This SfaNI-PCR-RFLP test is based on the polymorphism of a 677 bp fragment of the 
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TbAT1 gene (Afework et al., 2006; Delespaux et al., 2008b). T. brucei being not virulent for 
livestock, a diagnostic test for this species is of limited interest. Furthermore, the authors used 
strains that were resistant to both DA and ISM for the validation of their test rendering any 
interpretation of the results impossible. There is currently no satisfactory molecular test for the 
detection of ISM resistance in trypanosomes. 
 
2.6 Conclusion 
Chemotherapy and chemoprophylaxis have been the main methods of control and prevention 
of trypanosomosis. Nevertheless, the development of drug resistance has certainly brought 
doubt in their future application. The development of drug resistance is multi-factorial and has 
serious implication for countries that are almost entirely dependent on agriculture. Therefore, 
it is advisable to bring together all the stakeholders involved in the fight against the 
development of resistance and share the good practices across East Africa. Beyond the 
fragmented approach of control and prevention, the establishment of short and long term 
partnership with international organizations would certainly leverage the national and regional 
effort. Geospatial mapping of drug resistance nationally and in the region is also worth 
considering in order to identify drug resistance hot spot areas and tackling them subsequently. 
Such a map would also be helpful in establishing a field monitoring system that could be used 
to target field interventions more effectively and efficiently. Mapping the market chain for 
trypanocidal drugs both nationally and in the region would help to establish a regulatory 
mechanism for the marketing of trypanocidal drugs. Since the community should also be part of 
the drug resistance fighting program, extension education for livestock owners on different 
topics is required. This would involve preparation of generic booklets that contain information 
on the whole package of trypanocidal drug use which can be translated to respective countries 
local languages for subsequent use by livestock owners.   
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3.1 Abstract 
A cross-sectional study was carried out in the Ghibe valley from August to October 2010. A total 
of 411 head of cattle were sampled in eight villages for buffy coat examination (BCE) and blood 
spots were collected from each animal for trypanosomes diagnosis by 18S-PCR-RFLP and 
diminazene aceturate (DA) resistance by DpnII-PCR-RFLP. Three villages were selected from 
ILRI-priority zones (Abelti, Yatu and Keta Bosso where disease control is implemented) whereas 
the other five from non-priority zones (Weira, Jatu, Wedesa, Shumoro and Gomsho where no 
organized disease control is happening). Twenty-four samples (5.84%) were diagnosed positive 
for T. congolense by BCE and injected in mice for further characterization. Twelve of those 
isolates successfully multiplied in mice and were tested by an in vivo mouse test for diminazene 
(DA) (10 and 20 mg/kg B.W.) and isometamidium (ISM) (1mg/kg B.W.) resistance. All were 
shown to be resistant to both drugs at all doses. The use of the DpnII-PCR-RFLP on these 
isolates confirmed their DA-resistance profile. Seventy-three of the collected blood spots 
(17.8%) were diagnosed positive for T. congolense by 18S-PCR-RFLP of which 37 (50.7%) gave 
amplification products with the DpnII-PCR-RFLP. Here, 35 (94.6%) showed a resistant profile, 1 
(2.7%) a sensitive profile and 1 (2.7%) a mixed profile. The data were analysed by logistic 
regression model and the relapsing time in mice tests was assessed using the Cox regression 
model. There was no significant intervention effect (P=0.83) with odds ratio equal to 1.21 when 
using the BCE data. The 18S-PCR-RFLP test also showed no significant intervention effect 
(P=0.60) with odds ratio equal to 1.43. The hazard ratio of getting parasitaemic after treatment 
with DA at 20 mg/kg B.W. compared to the control group was 0.38 which differs significantly 
from one (P<0.001). Relapsing time after treatment with DA 10 mg/kg B.W. or ISM 1mg/kg B.W. 
was also significantly longer than the prepatent period of the control group. The situation of 
drug resistance in the Ghibe valley is further discussed. 
 
Keywords: Trypanosoma congolense, isometamidium, diminazene, Ghibe, Ethiopia, drug 
resistance 
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3.2  Introduction 
Tsetse-transmitted trypanosomes are responsible for diseases unique to Africa affecting both 
humans and animals. They occur in about 10 million km2 in 37 sub-Saharan countries (FAO, 
2002) and constitute a major threat to the survival and productivity of domestic livestock in 
sub-Saharan Africa (Holmes, 1997). Trypanosomes cause serious economic losses and an 
estimated annual loss in cattle production alone has been reported to be in the range of 1.0-1.2 
billion dollars (FAO, 2002). 
 
The situation of African Animal Trypanosomosis (AAT) has become even worse due to the fact 
that some drugs have been abandoned due to resistance (Matovu and Mäser, 2010). 
Practically, only ethidium bromide (Homidium®) and DA (Berenil®) are still available for therapy 
and ISM (Samorin®, Trypamidium®) for prophylaxis (Holmes, 1997; Geerts et al., 2001; Matovu 
and Mäser, 2010). The inevitable outcome of continued use of the same compounds for 
decades has resulted in drug resistance that has been largely considered responsible for the 
frequently observed chemotherapeutic failures. At present, trypanocidal drug resistance is 
reported in 18 countries of sub-Saharan Africa (Delespaux et al., 2008). Although tsetse and 
trypanosomosis research and intervention in the Ghibe Valley of Ethiopia has started a long 
time ago (Rowlands et al., 1993; Codjia et al., 1993; Mulugeta et al., 1997), the disease persists 
to exert its deleterious effects on the most vulnerable segment of the society. Resistance to 
commonly used drugs has been reported from different parts of Ethiopia including Ghibe 
Valley. For instance, Tewelde et al. (2004) reported ISM resistance of trypanosomes (T. 
congolense, vivax and brucei) infecting cattle in the upper Didessa valley of Western Ethiopia. 
Mulugeta et al.(1997) documented multiple drug resistance in T. congolense at the Ghibe river 
basin. Chaka and Abebe (2003) reported the existence of T. congolense resistance originally 
isolated from cattle in the Southwest of Ethiopia, namely, Ghibe, Bedelle, Sodo and Arbaminch. 
In view of today’s resistance reports from many parts of Ethiopia including Ghibe valley, 
intervention needs to be complemented with regular surveillance of the evolution of the 
trypanocidal drug resistance.  
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The aim of this study was to explore an easier and faster method of DA resistance diagnosis 
based on the DpnII-PCR-RFLP (Vitouley et al., 2011). Results from this DpnII-PCR-RFLP DA 
resistance test were compared with the gold standard, i.e., the mice test (Eisler et al., 2001), to 
evaluate the newly proposed molecular test. The mice test was also used to diagnose ISM 
resistance. Based on the comparative results of the two drug resistance tests, the actual 
situation of drug resistance in the Ghibe Valley is discussed.  
 
3.3 Materials and Methods 
3.3.1 Study area 
The Ghibe valley is 183 km away from Addis Ababa and located in Southwest Ethiopia. Farmers 
in and around the valley make their living by mixed farming systems and cattle production using 
traditional village management for subsistence (Leak et al., 1993). The area receives a mean 
annual rainfall of 900 mm and the mean monthly maximum temperature ranges from 29.8 to 
44.0⁰C (Leak et al., 1993; Rowlands et al., 2001). The Livestock Research Institute (ILRI) is 
running interventions against trypanosomosis using monthly DA (Vetiben®) administrations 
(3.5mg/KG B.W.) for all animals found infected and monthly deltamethrin (cypermethrin®) 
pour-on application (20 ml/adult animal) at the expenses of the community since 1990. The 
intervention covers two sites namely: upper and lower Ghibe and more than 20 villages benefit 
from this activity. Our study involved both ILRI-intervention and non-intervention sites around 
the Ghibe river valley. Intervention was decided in priority zones were the impact of the disease 
was considered by the farmers as the highest based on their own perceptions. A total of eight 
kebeles (smallest administrative unit of Ethiopia) were selected to include three from ILRI-
priority zones (Abelti, Yatu and Keta Bosso) and the other five from non-priority zones (Weira, 
Jatu, Wedesa, Shumoro and Gomsho). The vegetation coverage and thus, the tsetse habitat in 
the entire region are spotty and limited to the vegetation of the river banks or to protected 
forest zones because of the intensive agricultural expansion in the area. The choice of the 
kebeles was based on expert opinion taking into account a comparable vegetation of the river 
banks and equal distance between grazing zones and rivers to harmonize the tsetse challenge 
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between the 8 study sites. In the non-priority zones, veterinary drugs including trypanocidal 
drugs are available freely in all rural shops or local markets and the farmers don’t have the 
habit of presenting sick animals to veterinarians for proper diagnosis of diseases. Thus, the 
administration of drugs is usually done by the breeders often without veterinary advice. No 
information is available on the treatment frequencies, type of trypanocide, doses injected due 
to this unsupervised use of the drugs out of any legal sanitary framework. 
 
3.3.2  Cross-sectional study 
The cross-sectional study was carried out from August to October 2010. To obtain a 95% 
confidence interval for the prevalence of trypanosomosis that has a width equal to 10%, a 
minimum sample size of 384 animals was required, assuming that the real prevalence equals 
50% to plan for the maximum possible sample size (Thrusfield, 1995). Based on the sampling 
size pre-requisite, a total of 411 whole blood samples were collected from East African Zebu 
cattle in the study area. 
 
3.3.3 Animals 
A heterogeneous group of East African Zebu cattle in different age and sex categories was used 
for this study (198 males, 213 females, aged between 1 and 15 years old). Accordingly, all 
owners in every kebeles were informed to gather their animals the following day at the 
proposed sampling site. These 411 Zebu cattle were selected randomly using the lottery 
method. 
 
3.3.4 Blood collection  
From each cattle, 9 ml of whole blood was collected from the jugular vein into heparinised 
Venosafe tubes (Terumo) for further analysis.  
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3.3.5 Parasitological tests 
3.3.5.1 Buffy coat examination (BCE) 
The BCE was performed as described by Woo (Woo, 1970) immediately after blood collection in 
the field. Briefly, about 70μl of blood was collected in a microhaematocrit capillary tube and 
sealed on one end. The capillary tube was centrifuged at 15,000 rpm for 5 minutes to 
concentrate the trypanosomes in the buffy coat layer. Then, the capillary tube was placed in a 
Woo viewing chamber and a cover slip of 24x24 mm was placed on the capillary tube hereafter 
the space between the tubes and the cover slip was filled with a drop of water to reduce light 
diffraction. The buffy-coat plasma junction was examined for the presence of trypanosomes 
and the Packed Cell Volume (PCV) was measured. 
 
3.3.5.2  Isolation of Trypanosomes 
In the field, about 0.5 ml of blood samples BCE-positive for the presence of trypanosomes 
(single or mixed infections) were injected intraperitoneally into three mice aged from 5 to 8 
weeks and weighing on average 30 g each. When the parasitaemia reached a minimum of 7.1 
on the Herbert and Lumsden scale (Herbert and Lumsden, 1976), the blood was collected by 
cardiac puncture under final anaesthesia. This blood from mice was used to prepare 
cryostabilates stored in liquid nitrogen until further inoculation.  
 
3.3.5.3 Stabilate preparation 
The cryomedium was prepared in advance by mixing one part of egg yolk to three parts of 
phosphate saline glucose buffer (PSG) and to three parts of Triladyl® (Minitube). The 
ingredients were carefully mixed and divided in aliquots of 0.5 ml in Sarstedt microtubes 
(Sarstedt) and stored at -20°C until use. Stabilates were prepared by gently mixing 0.5 ml 
volumes of mice blood with confirmed presence of trypanosomes with an equal volume of 
thawed cryomedium in a Sarstedt microtube that was suspended in the vapor phase of liquid 
nitrogen for 1 hour before being immersed in the liquid phase for long term storage. 
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3.3.5.4 Drug resistance tests in mice 
This test was conducted after stabilate preparation in the laboratory and the protocol described 
by Eisler et al. (2001) was used with minor modifications. In this study, male and female Swiss-
white mice aged between 8 and 10 weeks and weighing between 25 to 30g were used. They 
were housed in clean cages at room temperature in fly-proof conditions, fed with commercial 
pellets and water ad libitum. The mice were screened for the presence of blood parasites using 
wet and Giemsa-stained thin blood films prior to the beginning of the experiment. 
 
Parasitaemic blood of each Trypanosoma isolate was diluted in PSG to obtain a final 
concentration of 105 trypanosomes per ml and inoculated into 4 groups of 6 mice each. Twenty 
four hours after inoculation, the mice of three groups were treated with the trypanocidal drugs. 
The first group was treated intraperitoneally with 1mg/kg B.W. ISM (Veridium®, Lot No. 173A1), 
the second and third groups with 10 and 20mg/kg B.W. DA (Veriben®, Lot No. 500A1), 
respectively. The control group was injected with distilled water. Mice were monitored twice a 
week for a period of two months for the presence of trypanosomes by the examination of wet 
smears of tail blood. An isolate was considered as resistant when more than one out of the 6 
treated mice became positive within the observation period. Two reference strains TRT8 and 
IL1180 sensitive to DA and ISM, respectively were added as quality control for the trypanocides 
used. The TRT8 isolate originates from cattle in the Eastern Province of Zambia and was then 
cloned visually from a single trypanosome. It shows a T. congolense savannah type profile with 
the 18S-PCR-RFLP and a DA-sensitive profile with DpnII-PCR-RFLP. The IL1180 isolate was 
described by Peregrine et al. (1997). 
 
3.3.6 Molecular assays 
3.3.6.1 Field Samples  
The buffy coat of 411 cattle were spotted on filter paper Whatman 4 (Whatman) in the field, 
dried protected from UV light and stored in plastic bags containing silica gel until further 
processing less than 4 months after preparation. 
Chapter 3  
71 
 
3.3.6.2  Samples from mice test 
Both treated and untreated mice showing trypanosomes circulating in peripheral blood were 
bled from the tail and blood was spotted on filter paper Whatman 4 (Whatman) dried 
protected from UV light and stored in plastic bags containing silica gel until further processing. 
 
3.3.6.3 Trypanosome species identification (18S-PCR-RFLP) 
DNA was extracted using the saponine-PBS method described by de Almeida et al.(1998). For 
species identification, DNA amplifications were performed using three primers targeting the 
18S small ribosomal subunit gene sequence and followed by digestion of the products using 
MspI enzyme as described by Geysen et al. (2003).  
 
3.3.6.4 Diminazene resistance test (DpnII-PCR-RFLP) 
Primers targeting the TcoNT10 gene coding for a P1-type purine transporter and the DpnII 
restriction enzyme were used as described by Delespaux et al. (2006) and modified by Vitouley 
et al. (2011) but without the described whole genome amplification step. The accession 
number of TcoNT10 gene is TcIL3000_9_2500 (http://www.genedb.org).  
 
3.3.7 Data analysis 
Prevalence and resistance, both binary response variables, were analysed by the logistic 
regression model introducing intervention as fixed effect and kebele as random effect. When 
the variation due to kebele is significantly different from zero, the prevalence (of resistance) 
varies significantly from kebele to kebele. The relapsing time according to drugs and doses was 
assessed using the Cox regression model with strain as stratum and drug regimen as categorical 
fixed effect. All tests were done at the 5% global significance level. All analyses were performed 
using SAS Version 9.2. 
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3.4 Results 
3.4.1 Prevalence and species identification 
Among the 411 samples tested, T. congolense was diagnosed in 24 (5.8%) and 73 (17.8%) blood 
samples using BCE and 18S-PCR-RFLP respectively. Nine (2.2%) samples were positive for both 
tests (Table 3.1). The 18S-PCR-RFLP confirmed that all the T. congolense were savannah type. A 
few T. vivax were observed in single or mixed infection with T. congolense but were not further 
considered in this study. 
 
Table 3.1 Summary of T. congolense infections based on different test methods  
Kebele Intervention Cattle 
sampled 
BCE 18S-PCR-
RFLP 
Both tests 
positive 
Wedesa No 38 2 11 1 
Shumoro  No 63 3 19 2 
Gomsha  No 14 0 0 0 
Jatu  No 34 5 4 3 
Weira No 50 0 1 0 
Yatu Yes 75 11 17 3 
Keta Bosso Yes 76 2 8 0 
Abelti Yes 61 1 13 0 
Total   411 24 (5.8%) 73 (17.8%) 9 (2.2%) 
 
 
The prevalences observed in priority zones and non-priority zones were comparable (P=0.83) 
with odds ratio equal to 1.21 (95% CI: 0.24 - 6.02) when using the BCE data. The variance of the 
random kebele effects was equal to 0.77 (SE=0.71) and did not differ significantly from zero 
(P=0.31). Similarly, 18S-PCR-RFLP test showed similar prevalences in priority and non-priority 
zones (P=0.60) with odds ratio equal to 1.43 (95% CI: 0.40 - 5.23). The variance of the random 
kebele effects was equal to 0.59 (SE=0.49) and did not differ significantly from zero (P=0.27). 
Therefore, in both test methods, we cannot conclude that there was over-dispersion rather the 
prevalence was uniform over kebeles.  
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3.4.2 DpnII-PCR-RFLP resistance study 
All 73 samples positive for T. congolense savannah type using the 18S-PCR-RFLP were tested for 
DA susceptibility using the DpnII-PCR-RFLP (Table 3.2). Among the 73 samples, 37 (50.7%) gave 
amplification products. Among the 37 positive, 35 (94.6%) showed resistant profiles, 1 (2.7%) 
sensitive and 1 (2.7%) mixed profiles. There was almost no variation in resistance over the 
different kebeles, as almost all the strains were found to be resistant. 
 
Table 3.2 Diminazene resistance results of T. congolense using DpnII-PCR-RFLP according to 
study sites  
Kebele Intervention 18S-PCR-RFLP   DpnII-PCR-RFLP   
    Positive Amplified Resistant Sensitive Mixed 
Wedesa  No 11 8 8 0 0 
Shumoro No 19 8 8 0 0 
Gomsha No 0 0 0 0 0 
Jatu  No 4 2 2 0 0 
Weira No 1 0 0 0 0 
Yatu  Yes 17 8 7 0 1 
Keta 
Bosso  
Yes 8 5 4 1 0 
Abelti  Yes 13 6 6 0 0 
Total   73  
(17.8%) 
37 
(50.7%)a 
35  
(94.6%)b 
1  
(2.7%)b 
1 
(2.7%)b 
a % of the 18S-PCR-RFLP positive 
b % of the 18S-PCR-RFLP positive that also amplified using DpnII-PCR-RFLP  
 
3.4.3 T. congolense isolation 
Among the 24 fresh blood samples that were diagnosed as T. congolense by BCE and injected 
into mice, 12 (50%) were successfully isolated and preserved in liquid nitrogen.  
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3.4.4 Resistance tests in mice 
The 12 T. congolense isolates were found resistant to DA at 10 and 20 mg/kg B.W. The median 
prepatent period was 9 and 12 days for 10 and 20 mg/kg B.W. DA treatment groups 
respectively. The same isolates were found resistant to ISM at the dose of 1 mg/kg B.W. and 
the median prepatent period was 8.8 days (Table 3.3). 
 
Table 3.3 Median prepatent periods according to doses and treatments of T. congolense 
infections in mice  
Group  
 
Median PPa (days) Minimum PPa (days) Maximum PPa (days) 
Control  8 6 13 
ISM 1 mg 8.75 6 60 
DA 10 mg 9 6 25.5 
DA 20 mg  12 8.5 20 
aPrepatent period 
 
The hazard ratio of getting parasitaemic after treatment with DA at 20 mg/kg B.W. compared to 
the control group was 0.38 (95%, CI: 0.26 - 0.56) which differs significantly from one (P<0.001). 
Relapsing time after treatment with DA 10 mg/kg B.W. or ISM 1mg/kg B.W. was also 
significantly longer than the appearance of parasites in the control group. As expected, the 
sensitive strain TRT8 did not relapse in mice after treatment as confirmed by negative 
microscopical examination and 18S-PCR-RFLP during the two months of observation. 
 
3.4.5 18S and DpnII-PCR-RFLP on samples from mice 
All 12 isolates were confirmed to be T. congolense savannah type and resistant to DA using 
DpnII-PCR-RFLP with blood spotted on filter papers from mice. The samples collected in the 
field and spotted on filter paper corresponding to those 12 isolates were also checked with the 
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two PCR-RFLP’s. Only six (50%) of those field samples gave PCR amplification products. All were 
confirmed to have a DA-resistant profile. 
 
3.4.6 Mice isolation versus BCE and 18S-PCR-RFLP on DNA from filter papers 
For the 24 samples that were diagnosed in the field as T. congolense by BCE and inoculated in 
mice, the similarities and discrepancies between the BCE and molecular identification 
techniques are summarized in table 3.4.  
 
From the 24 samples, 9 were diagnosed correctly by both tests, 12 were negative with the 18S-
PCR-RFLP, 1 was characterized as T. theileri by 18S-PCR-RFLP, 1 mixed infection T. congolense-
vivax was found to be T. theileri by 18S-PCR-RFLP, another mixed infection T. congolense-T. 
vivax was diagnosed as T. vivax by 18S-PCR-RFLP. More importantly, the 18S-PCR-RFLP detected 
three times more positives than the microscopic examination. 
 
3.5 Discussion - conclusions 
The aims of this survey were to evaluate the current situation of trypanocidal drug resistance in 
the Ghibe valley using fast and easy molecular methods and validating those results by tests in 
mice. To achieving this, the molecular tests were performed on 411 samples from which a 
subset (24 samples that were microscopically trypanosome positive in BCE) was also tested in 
an in vivo mouse test for drug resistance. When examining the discrepancies between the BCE 
and 18S-PCR-RFLP (Table 3.4), it might seem intriguing that positive samples by microscopical 
examination were found negative by PCR-RFLP. This is probably due to the low concentration of 
parasites and the random effect created by the low volume of blood (50μl – the content of a 
capillary tube) examined by both methods. A parasitaemia of 20 trypanosomes/ml blood 
corresponds to 1 single trypanosome in 50μl.  
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Table 3.4 Summary of discrepancies between 18S-PCR-RFLP and BCE for 24 mice injected 
samples  
Isolates Ref No Kebele BCE 18S-PCR-RFLP DpnII-PCR-RFLP Isolated 
F042 Shumoro T.c. N N No 
F072 Shumoro T.c.-T.v. T.c. N No 
F127 Jatu T.c. N N No 
F140 Jatu T.c.  T.c. N No 
F153 Yatu T.c.+T.v. N N No 
F159 Yatu T.c.+T.v. T.v. N No 
F165 Yatu T.c. N N No 
F171 Yatu T.c. N N No 
F178 Yatu T.c. N N No 
F189 Yatu T.c.+T.v. T.th. N No 
F244 Keta Bosso T.c. T.th. N No 
F246 Keta Bosso T.c.+T.v. N N No 
F015 Wedessa T.c. T.c. R Yes 
F018 Wedessa T.c. N N Yes 
F058 Shumoro T.c. T.c. R Yes 
F119 Jatu T.c. N N Yes 
F125 Jatu T.c. T.c. R Yes 
F148 Jatu T.c. T.c. R Yes 
F164 Yatu T.c.+T.v. N N Yes 
F166 Yatu T.c. U N Yes 
F172 Yatu T.c.+T.v. T.c. N Yes 
F187 Yatu T.c.+T.v. T.c. R Yes 
F203 Yatu T.c. T.c. R Yes 
F393 Abelti T.c. N N Yes 
With T. c. as T. congolense; T.v. as T. vivax; T. th. As T. theileri; N as no amplification; U as unidentified 
and R as resistant 
 
The probability of getting a 50μl sample with no parasite is thus not negligible. Furthermore, 
the buffy coats that are examined with the microscope or that are submitted to PCR-RFLP 
diagnosis are two different individual samples. It is thus expected to find some discrepancies 
between the two methods. An option to avoid this problem could be to replace the sampling on 
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filter paper by whole blood (500μl) mixed to a protective buffer such as AS1 (Qiagen®) or a 6M 
guanidine hydrochloride / 0.2 M EDTA buffer (Avila et al., 1990). This alternative presents a 
double advantage: (i) the sampling volume is larger, increasing the probability of getting at least 
one trypanosome in the collected blood and (ii) it decreases the risk of contamination between 
samples. This is usually not a big issue as all samples are stored individually and as the 
parasitaemia is normally very low but it can constitute a hinder in cases of high parasitaemias 
as it is observed in some spots (Moti et al., unpublished data). The 18S-PCR-RFLP was as 
expected, more sensitive than BCE with three times more positive samples. Our results (17.8%) 
with the 18S-PCR-RFLP for the prevalence of trypanosomosis are in concordance with previous 
studies (13.3%) (Rowlands et al., 2001).  
 
The results of the species determination with T. congolense savannah type as predominant 
species are also comparable with previous studies (Mulugeta et al., 1997).The prevalence of T. 
congolense infections using BCE fluctuated around 5 to 6% and were not significantly different 
across the 8 kebeles. Our results indicate that the monthly systematic administration of DA 
(Veriben®) and deltamethrin pour-on treatment in the priority zones manage to reduce the 
burden of the disease to a level comparable to the non priority zones where no systematic and 
organized interventions were found necessary. There, the control relies on the sole 
administration of trypanocidal drugs based on clinical signs or breeder assumptions. The fact 
that farmers continue administrating trypanocides even when the presence of drug resistance 
is confirmed in the region, might be not surprising as it was demonstrated that even for 
infections with drug resistant trypanosomes the treatment with trypanocides remained 
beneficial. In an experimental model where cattle was inoculated with ISM-resistant T. 
congolense and treated at the first peak of parasitaemia, the impact of the infection on the PCV 
was not very pronounced with an average PCV reduction 8 to 14 weeks after treatment of only 
5.9% (95% CI: 4.5-7.3) (Delespaux et al., 2010). Limiting the treatment to anaemic animals 
would certainly decrease the volume of drugs used as well as the costs for the farmers as 
recommended by Van den Bossche and Delespaux (2011). 
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Cases of drug resistance in the Ghibe valley has been described earlier. Rowlands et al. (1991) 
documented 12/12 isolates resistant to DA and 11/12 isolates to ISM in South-Western 
Ethiopia. Codjia et al. (1993) collected 12 isolates from cattle bred in the Ghibe valley and 
reported resistance to the maximum recommended dose of DA (7.0 mg/kg B.W.). Later, in the 
same region, concerns raised about the threat of drug resistance for the efficiency of animal 
production (Mulugeta et al., 1997; Chaka and Abebe, 2003). Tewelde et al. (2004) also reported 
ISM resistance in cattle sampled from upper Didessa valley of Western Ethiopia by the use of 
block treatments (Eisler et al., 2000). Our study shows that molecular tools greatly facilitate the 
diagnosis of DA resistance allowing for more large scale surveys but still has to be 
complemented by tests in mice or block treatments for the diagnosis of ISM resistance as no 
trustable molecular tool has been developed for this drug. 
 
The molecular technique for the diagnosis of DA resistance in T. congolense proved to be 
sensitive, fast and reliable even if only half of the samples positive with the 18S-PCR-RFLP gave 
amplification products with the DpnII-PCR-RFLP. This can be explained by the fact that the 
target gene of the 18S-PCR-RFLP is multicopy as opposite to the target gene of the DpnII-PCR-
RFLP which is a single copy gene. The correlation between the DpnII-PCR-RFLP and the gold 
standard (test in mice) was 100% as all 12 isolates tested in mice for DA-resistance were also 
diagnosed as such by the molecular tool allowing for a reliable extrapolation to all the T. 
congolense isolates. 
 
The test in mice complements the DpnII-PCR-RFLP by providing information on ISM resistance. 
All isolates were resistant to ISM too jeopardizing thus the use of the sanative pair to overcome 
drug resistant trypanosomes as proposed by Whiteside (1962). Briefly, the concept of the 
sanative pair recommends the use of two trypanocides (e.g. DA and ISM) which are chemically 
unrelated and, therefore, are unlikely to induce cross-resistance. The first of the pair is used 
until resistant strains of trypanosomes appear and then the second is substituted and used until 
the resistant strains have vanished from cattle and tsetse (Whiteside, 1962). 
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The relative control of the disease in the area, despite the high level of drug resistance, is a 
relief as a recent resettlement program launched in the region by the government for farmers 
from draught struck areas is placing the Ghibe Valley under high pressure for food production 
(Getachew, 2005; Lemecha et al., 2006). 
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4.1 Abstract 
The present study aimed to compare the trypanosome specific 18S-PCR-RFLP using samples 
stored either on Whatman filter papers (PCR-RFLP-fp) or in a commercial cell lysis and DNA 
protecting buffer (PCR-RFLP-pb) with the haematocrit centrifugation technique (HCT), a method 
widely used for the diagnosis of African Animal Trypanosomosis. Out of 411 head of cattle, 49 
(11.92%) (CI = 8.95-15.45) scored positive for the presence of trypanosomes by HCT whereas 75 
(18.25%) (CI = 14.63-22.33) and 124 (30.17%) (CI = 25.77-34.86) scored positive using PCR-RFLP-
fp and PCR-RFLP-pb, respectively. Out of the 49 positives by HCT, 14 (28.57%) (CI = 16.58-43.26) 
and 28 (57.14%) (CI = 42.21-71.18) were concordant by PCR-RFLP-fp and PCR-RFLP-pb, 
respectively. None of the PCR techniques detected parasites from the Trypanozoon group. 
Although HCT detected more cases of T. vivax (33), species identification using PCR-RFLP-fp and 
PCR-RFLP-pb were significantly different (p < 0.001) from the HCT technique. The use of DNA 
protective buffer is thus recommended as the output of the PCR-RFLP-pb is improved and the 
risk of contamination between samples is reduced. 
 
Keywords: Trypanosoma, Buffer, Ethiopia, Cattle, Trypanosoma vivax, Trypanosoma congolense 
 
4.2 Introduction 
African Animal Trypanosomosis (AAT) is a parasitic disease that causes serious economic losses 
in the livestock production system. Diverse clinical signs are observed from anaemia, loss of 
body condition and emaciation to death when untreated. In sub-Saharan Africa, the disease is 
caused by Trypanosoma congolense, Trypanosoma vivax and Trypanosoma brucei. Its 
distribution overlaps with the presence of the tsetse fly except for T. vivax and Trypanosoma 
evansi that can be transmitted mechanically by other hematophagous biting flies (CFSPH, 
2009). AAT restricts agricultural production, limits the availability of food and contributes to 
poverty across rural sub-Saharan Africa (Grady et al., 2011).  
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Accurate diagnosis of trypanosome infections is required for a proper understanding of the 
epidemiology of the disease, which can then result in the implementation of adequate control 
strategies (FAO, 1992; FAO, 1998; Getachew, 2005). The diagnosis mainly involves examination 
of clinical signs and laboratory methods. A presumptive field diagnosis is often based on finding 
an anaemic animal with a poor body condition in an epidemic or endemic area. Even then, 
because of the various clinical manifestations, diagnosis of trypanosomosis cannot be based on 
these clinical signs alone (Nantulya, 1990) as no pathognomonic clinical sign can confirm the 
disease. The presence of the parasite must thus be confirmed to ensure a proper diagnosis. 
Different techniques are therefore more or less routinely used by veterinarians: direct 
microscopy, concentration techniques, laboratory animal inoculation, detection of anti-
trypanosomal antibodies and molecular assays (Moser et al., 1989; Murray et al., 1977; 
Nantulya, 1990). Each of these techniques presents some strong and weak points.  
 
Serodiagnosis is a sensitive method but does not differentiate active infections from cured 
ones, nor does it distinguishes between different species of trypanosomes due to a poor 
specificity of the method (Desquesnes, 1997). However, Bossard et al. (2010) recently 
developed an inhibition ELISA based on the Heat Shock Protein 70 that is closely related to the 
mammalian Immunoglobulin Binding Protein. The specificity of this method has been reported 
to be much better than previous tests. 
 
Parasitological techniques such as the haematocrit centrifugation technique (HCT), Buffy Coat 
examination (BCE) and stained blood smear examination have been reported to be of low 
sensitivity but good specificity (Gardiner, 1989). These techniques are of limited significance 
when parasitaemias are low as often observed in endemic areas (Desquesnes, 1997).  
 
The polymerase chain reaction (PCR) has been reported to be the most sensitive and speciﬁc 
technique to detect trypanosomal DNA in either the vector or the host (Delespaux et al., 2006; 
Geysen et al., 2003; Lefrancois et al., 1998; Majiwa et al., 1993; Reifenberg et al., 1997; Solano 
et al., 1999). There have been several advances in the development of PCR using different 
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primer sets for the identification of trypanosomes at species and sub-species level. For 
instance, Masiga et al. (1992) designed oligonucleotide primers targeting the satellite DNA 
monomer to accurately identify T. simiae, T. congolense, T. brucei and T. vivax. Geysen et al. 
(2003) developed a semi-nested PCR-Restriction Fragment Length Polymorphism (RFLP) based 
on the 18S ribosomal small subunit for the detection of all trypanosome species including the 
three subtypes of T. congolense using three primers. Desquesnes et al. (2001) identified the 
three T. congolense subtypes, the Trypanozoon group, T. vivax, T. simiae and Trypanosoma 
theileri using a single PCR based on the Internal Transcribed Spacer 1 (ITS-1) of rDNA. However, 
PCR has been scarcely applied to assess the prevalence of trypanosomosis on ﬁeld samples, due 
to its time-consuming and costly aspects as well as the requirement for technical expertise 
(Solano et al., 1999). For our study, the semi-nested PCR-RFLP developed by Geysen et al. 
(2003) was preferred to other molecular methods because of its high sensitivity (multicopy 
gene) and its ability of differentiating the three subtypes of T. congolense. This PCR cannot 
differentiate species within the trypanozoon group but being not or weakly pathogenic for 
cattle, this issue was not considered as a constraint.  
 
Separating the sampling from the laboratory PCR activities involves the storage of the biological 
material for later processing. This might constitute a critical point as contamination between 
samples can easily occur in field conditions. Replacing the conventional filter papers for storage 
by blood aliquots preserved in a DNA protecting buffer decreases the time for the preparation 
of buffy-coats spotted on filter papers (e.g. impregnation, drying and storage), decreases also 
the potential contact between samples and thus the risk of contamination. Furthermore, the 
volume of blood that is collected is larger and subsequently allows the extraction of more 
target DNA. This should allow a higher number of detected cases by the PCR-RFLP. The 
objective of this study was to compare the detection of parasites by HCT, a technique routinely 
used in the field, with PCR-RFLP on samples that were stored either on Whatman® filter papers 
(PCR-RFLP-fp) or in a DNA protecting buffer (PCR-RFLP-pb). In the absence of gold standard, 
specificities and sensitivities were not calculated. 
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4.3 Materials and Methods 
4.3.1 Study animals and site  
A heterogeneous group of 411 cattle of different ages and sexes were selected from different 
villages (kebeles) in and around the Ghibe valley, South-Western Ethiopia (Jimma and Gurage 
zones). Details on the epidemiology of trypanosomosis and trypanocidal drug resistance in the 
area have been mentioned elsewhere in Fikru et al. (2012) and Moti et al. (2012) respectively. 
 
4.3.2 Protocol 
4.3.2.1 Blood sample collection 
From each animal, whole blood was collected by puncture of the jugular vein into 5 ml 
heparinized Venosafe® tubes (Terumo Europe) for further analysis using haematocrit 
centrifugation technique and molecular assay.  
 
4.3.2.2 Haematocrit Centrifugation Technique (HCT)  
The blood samples were then examined using the HCT as described by Woo (1970). Briefly, 
blood was collected in a microhaematocrit capillary tube and sealed on one end. The capillary 
tube was centrifuged at 15,000 rpm for 5 minutes to concentrate the trypanosomes in the buffy 
coat layer. Then, the capillary tube was placed in a Woo viewing chamber and a cover slip of 
24x24 mm was placed on the capillary tube. The space between the tubes and the cover slip 
was filled with a drop of water to reduce light diffraction. The buffy-coat plasma junction was 
examined for the presence of trypanosomes and species was identified through the type of 
their motility. The Packed Cell Volume (PCV) was also measured and a value below 24 % was 
considered as anaemia (Marcotty et al., 2008).  
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4.3.2.3 Molecular assay 
4.3.2.3.1 Preparation of the buffy coats spotted on filter paper and DNA extraction 
The buffy coat was prepared from about 50μl of heparinized blood in plain capillary tubes and 
was extracted from each capillary tube after the HCT was completed by cutting the tube 
approximately 1 mm below the red cell/plasma interface. The buffy coat from each tube was 
spotted on filter papers (Whatman® n° 4, GE Healthcare Bio-Sciences AB, Sweden) and dried 
protected from direct sun light and flies. The filter papers were kept in individual envelopes and 
then in a plastic bag containing silica gel for storage at 2-8°C (refrigerator) until further 
processing.  
 
DNA extractions were done using the saponin-PBS method described by de Almeida et al. 
(1998). Briefly, four confetti’s of 5 mm in diameter i.e. approximately 2/3 of the total surface of 
the dried buffy coat spot, were punched out for DNA extraction using 10% Chelex® (BIORAD, 
Belgium). To avoid contamination, two stainless steel punching tools were alternated after they 
were flame-sterilized and cooled.  
 
4.3.2.3.2 Whole blood in protecting buffer and DNA extraction  
Aliquots of whole blood (800μl) were kept in an equal volume of AS1 buffer® (Qiagen, USA) for 
cell lysis and DNA preservation at ambient temperature for a period of less than 3 months. DNA 
extraction was done from 200μl of blood/AS1 buffer® combination using QIAamp mini blood 
kit® according to the manufacturer's instructions (Qiagen, USA). Extracted DNA was stored at -
20°C till further processing.  
 
4.3.2.3.3 Trypanosome species identification 
For species identification, DNA amplifications were done using three primers targeting the gene 
coding for the small ribosomal subunit 18S (semi-nested PCR) and followed by digestion of the 
amplicons using Msp1 enzyme (New England BioLabs, USA) as described by Geysen et al. 
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(2003). PCR conducted on DNA extracted from buffy coat spotted on filter paper was 
abbreviated PCR-RFLP-fp. When the DNA extraction was performed from whole blood in 
protection buffer PCR-RFLP-pb was used. 
 
4.3.3 Data analysis 
The percentage of positivity for each trypanosome species detected by the different methods 
together with their 95% exact (Clopper-Pearson) confidence intervals was calculated. 
Techniques (HCT and PCR-RFLP's) were compared pairwise with respect to estimated 
prevalences by the Fisher exact test at the 5% significance level. The distribution of the positive 
cases of T. vivax and T congolense was also compared pairwise between the methods by the 
Fisher exact test at the 5% significance level using SAS Version 9.3 (SAS Institute Inc., Cary, NC, 
USA).  
 
4.4 Results 
4.4.1 Percentage positivity using different sampling methods 
Compared to HCT, the percentage of positivity for the presence of trypanosomes  was 
increased by more than 50% and 250% when using PCR-RFLP-fp and PCR-RFLP-pb respectively 
(see Table 4.1). The percentages of positivity for the three tests were statistically different from 
each other when compared two by two (p < 0.001). The non-pathogenic  trypanosome species 
T. theileri was excluded from the analysis to avoid exaggerating the differences between the 
tests during comparison. 
 
4.4.2 Comparison of HCT and PCR-RFLP-fp  
Out of 49 HCT positive samples, 14 (28.57%) (CI = 16.58-43.26) also scored  positive when using 
PCR-RFLP-fp. In contrast, PCR-RFLP-fp detected more positive cases compared to HCT, but the 
difference was not statistically significant (Table 4.2).  
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Table 4.1 The number and percentage of positivity of trypanosome infections detected by HCT, 
PCR-RFLP-fp and PCR-RFLP-pb in cattle blood samples from Ethiopia   
 
Species HCT positive  
N (% - LCL/UCL) 
PCR-RFLP-fp positive  
N (% - LCL/UCL) 
PCR-RFLP-pb positive  
N (% - LCL/UCL) 
Tc 16 (3.89-2.24/6.25) 73 (17.76-14.19/21.81) 100 (24.33-20.26/28.78) 
Tv 23 (5.60-3.58/8.28) 2 (0.49-0.06/1.18) 23 (5.56-3.58/8.28) 
Tc + Tv 8 (1.95-0.84/3.80) 0 (0.00/0.089) 1 (0.2-0.01/1.35) 
T + Tv 2 (0.49-0.06/1.18) 0 (0.00/0.089) 0 (0.00/0.089) 
Total 49 (11.92–8.95/15.45) 75 (18.25–14.63/22.33) 124 (30.17–25.77/34.86) 
With HCT: haematocrit centrifuge technique, PCR-RFLP-fp: 18S-PCR-RFLP using samples stored on 
Whatman filter papers, PCR-RFLP-pb: 18S-PCR-RFLP using samples stored in a commercial cell lysis and 
DNA protecting buffer, N: number, LCL: lower confidence level, UCL: upper confidence level, Tv:T. vivax; 
Tc: T. congolense savannah; T: Trypanozoon. 
 
 
Table 4.2 Comparison of the detection of trypanosome infection using HCT, PCR-RFLP-fp and 
PCR-RFLP-pb on cattle blood samples from Ethiopia   
 PCR-RFLP-pb 
Negative 
PCR-RFLP-pb 
Positive 
Total 
HCT Negative PCR-RFLP-fp 
Negative 
243 58 301 
PCR-RFLP-fp 
Positive 
23 38 61 
Total 266 96 362 
HCT Positive PCR-RFLP-fp 
Negative 
11 24 35 
PCR-RFLP-fp 
Positive 
10 4 14 
Total 21 28 49 
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Table 4.1. shows the results of species identification. Out of 411 samples, 24 (5.8%) were 
detected as T. congolense savannah by HCT (16 single and 8 mixed) whereas PCR-RFLP-fp 
detected 73 (17.8%)  positives  (all single); 33 (8.0%) (CI = 5.59-11.09) were detected  as T. vivax 
by HCT (23 single and 10 mixed) whereas PCR-RFLP-fp detected 2 (0.48%) (CI = 0.06-1.75) (all 
single). None were detected as Trypanozoon by PCR-RFLP-fp  whereas HCT detected 2 (0.5%) (2 
mixed). The difference in species identification using PCR-RFLP-fp compared to HCT was 
statistically significant  (p < 0.001).  
 
4.4.3 Comparison of HCT versus PCR-RFLP-pb  
Out of 49 HCT positive samples, 28 (57.1%)  also scored positive when using PCR-RFLP-pb. On 
the other hand, PCR-RFLP-pb detected more positives  compared to HCT (Table 4.2) and the 
difference was statistically significant (p < 0.001).  
 
For species identification, out of 411 samples, 24 (5.84%) (CI = 3.78-8.56) were detected  as T. 
congolense savannah by HCT (16 single and 8 mixed) whereas PCR-RFLP-pb detected 101 
(24.57%) (CI = 20.49-29.03) positives (100 single and 1 mixed); 33 (8.02%) (CI = 5.59-11.09) were 
detected  as T. vivax by HCT (23 single and 10 mixed) whereas PCR-RFLP-pb detected 24 (5.8%) 
(CI = 3.78-8.56) (23 single and 1 mixed); 2 (0.48%) (CI = 0.06-1.75) were detected  as 
Trypanozoon by HCT (2 mixed) whereas PCR-RFLP-pb detected none. Difference in species 
identification using PCR-RFLP-pb compared to HCT was statistically significant (p < 0.001).   
 
4.4.4 Comparison of PCR-RFLP-pb and PCR-RFLP-fp 
Out of 124 PCR-RFLP-pb positive samples, 42 (33.9%) (CI = 26.37-43.25) also scored  positive 
when using PCR-RFLP-fp. On the other hand, PCR-RFLP-fp detected 33 positives  that were not 
detected by PCR-RFLP-pb. The difference in detection of infection was statistically  significant (p 
< 0.001). 
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For species identification, out of 411 samples, 101 (24.57%) (CI = 20.49-29.03) were detected as 
T. congolense savannah by PCR-RFLP-pb (100 single and 1 mixed) whereas PCR-RFLP-fp 
detected 73 (17.76%) (CI = 14.19-21.81) cases (all single); 24 (5.84%) (CI = 3.78-8.56) were 
detected as T. vivax by PCR-RFLP-pb (23 single and 1 mixed) whereas PCR-RFLP-fp detected 2 
(4.87%) (CI = 0.6-1.75) (all single); no Trypanozoon was detected by none of the PCR. 
Considering T. congolense and T. vivax detection, the percentage positivity was higher with 
PCR-RFLP-pb (p < 0.001). 
 
4.4.5 Relationship of PCV value with HCT and PCR-RFLP-fp or -pb 
The mean PCV was 26.2±5.0 and anaemic condition of the animal (PCV < 24) was found 
matching with diagnostic test positivity for trypanosomosis in 29 (59.2%) (CI = 44.23-73.01), 36 
(48%) (CI = 36.35-60.07) and 53 (42.7%) (CI = 34.21-52.30) cases for HCT, PCR-RFLP-fp and PCR-
RFLP-pb, respectively (Table 4.3). 
 
Table 4.3 Relationship between PCV category and presence of trypanosomes infection with the 
three different tests used on cattle blood from Ethiopia  
PCV 
category  
HCT  
+N (%, LCL/UCL)  
PCR-RFLP-fp                  
+N (%, LCL/UCL) 
PCR-RFLP-pb                 
+N (%, LCL/UCL) 
PCV < 24      
(n = 109) 
29 (59.2-44.23/73.01) 36 (48-36.35/60.07) 53 (42.7-34.21/52.30) 
PCV ≥ 24      
(n = 302)  
20 (40.82-28.06/54.94) 39 (52.00-40.78/63.02) 71 (57.26-48.42/65.66) 
Total            
(n = 411) 
49  75 124 
With N: number; LCL: lower confidence level; +: positive; UCL: upper confidence level 
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4.5 Discussion 
The aim of this study was to compare the HCT with the PCR-RFLP on samples from the same 
animal but stored under two different conditions, i.e. either buffy coat spots on filter paper or 
whole blood in lysis/stabilization buffer. Filter papers are commonly used to store blood or 
buffy coat samples for epidemiological surveys. This method for field sample storage presents 
multiple advantages as a low cost, a low weight allowing easy transport and long term 
preservation. However, two important drawbacks were observed from a long time practice in 
the field i.e. a potential contamination between samples by contact between the filters or 
unclean hands of the technician and the low quantity of blood that is effectively used for DNA 
extraction. To overcome these drawbacks, an alternative storage method is available using a 
commercial buffer (QIAGEN AS1® - QIAGEN, USA) that is lysing the cells and protecting the DNA 
present in the solution for several months at ambient temperature. 
 
The main outcome of this study is clearly better trypanosome detection with PCR performed on 
DNA extracted from a larger volume of whole blood (± three times the volume). The larger the 
volume of the blood sample used for DNA extraction, the higher the probability of detecting 
trypanosomes at low concentration. PCR-RFLP-fp method is performed routinely with 30 μl 
aliquots and PCR-RFLP-pb with 100 μl blood samples. The number of positives would have 
certainly increased if  QIAGEN Midi-kit® (uses up to 2ml blood) was used rather than the Mini-
kit (uses up to 200 μl blood) for the DNA extraction. However, the price has to be considered 
with 0.44€ and 7€ for the mini and midi kits, respectively. In our study, the detection efficiency 
of the PCR was higher (124 against 75) when using PCR-RFLP-pb compared to PCR-RFLP-fp. The 
65% gain in detection might however be less than expected when tripling the volume of the 
sample used for DNA extraction. An explanation could be a lower efficiency of the QIAGEN kit 
compared to the chelex-based extraction. However Hsiang et al. (2010) reported that the two 
methods were equally efficient.   
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Beside the considerations made here above, some results deserve more accurate observation 
such as (i) negative PCR’s that coincide with a positive HCT, (ii) two samples that were detected 
as T. vivax by PCR-RFLP-fp and as T. theileri by PCR-RFLP-pb. 
 
Due to the sampling procedure i.e. a simultaneous processing of the microscopic examination 
and preparation of the buffy coats on filter paper or blood in the protective buffer, detection of 
trypanosome was done for each animal on three independent samples (obtained from the 
bleeding of the same animal, but being three distinct aliquots from the same 5 ml Vacutainer® 
tube). Parasitaemia observed in the field are commonly oscillating between the detection limits 
of the HCT and of the 18S-PCR being around 250-500 parasites/ml and 25 parasites/ml, 
respectively (Geysen et al., 2003; Paris et al., 1982). These low parasitaemia are likely to explain 
some differences between the aliquots that are tested with the different methods. Some 
capillary tubes filled from the same 5 ml Vacutainer® tube might contain no trypanosome or a 
cluster of trypanosomes or even different species of trypanosomes. As stated above, the 
detection limit of the 18S-PCR is situated around 25 trypanosomes/ml meaning about 1 
trypanosome/capillary tube. At this low level of parasitaemia, some of the capillaries may 
contain 1, 2 or more trypanosomes and some may be empty. This situation was previously 
reported by Junqueira et al. (1996) with negative PCR’s correlated to positive xenodiagnosis. 
This is likely the explanation of the positive HCT versus negative PCR and the two samples that 
were detected as T. vivax by PCR-RFLP-fp and as T. theileri by PCR-RFLP-pb. 
 
The number of T. vivax detected by HCT (33) was significantly higher than by PCR-RFLP-fp and 
PCR-RFLP-pb that detected 2 and 24, respectively. A lower sensitivity for T. vivax detection 
using an 18S based PCR had already been reported elsewhere (Njiru et al., 2005). This might be 
explained by the limited sensitivity of the PCR for this particular species linked to a high genetic 
diversity of the 18S locus. Additionally, the microscopical observation of T. vivax is strongly 
facilitated by the high mobility of this species. On the other hand, the PCR-RFLP-fp and PCR-
RFLP-pb detected more T. congolense infections than the ITS1 PCR on the same samples (Fikru 
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et al. 2012). The discrepancy in this case can be explained by the fact that the 18S-PCR is a 
semi-nested PCR with, in principle, a lower detection limit. 
 
Finally, the question should be raised to know if the infection or the disease has to be 
diagnosed. This was already explored for trypanosomosis in goats in Burkina Faso where sick 
animals were always microscopically positive (Vitouley et al., 2012). Diagnosing the disease 
with a less sensitive method like the HCT keeps its full sense in the strategies aiming at reducing 
the economic impact of the disease at the herd level. In our study, the proportion of anaemic 
animals was higher in the HCT positive animals (59.2%) compared to 48% and 42.7% for PCR-
RFLP-fp and PCR-RFLP-pb, respectively. HCT remains a robust field method as it will be more 
efficient than PCR to detect clinical cases that have to be treated. Indeed, in routine veterinary 
practice diagnosing the disease remains the priority compared to detecting parasites. 
Alternatively, the PCR constitutes a valuable tool for epidemiological surveys and for drug 
efficacy testing where an evidence of cure is necessary. The parasitological technique combined 
with the clinical examination is ideal when the focus is on the disease. The molecular 
techniques are useful when the focus is on the presence of the parasite (presence/absence, 
geographic distribution, herd prevalences). The multi-species PCR present the advantage of 
decreasing the work load and the final cost of the operation. Only one PCR has to be done on 
each sample and the restriction step for species diagnosis applies only for the positives. 
 
4.6 Conclusion 
Major differences were observed during this study between the detection of trypanosome by 
the three methods. Therefore, it is of a high importance to consider carefully the protocol of 
any trypanosome prevalence survey before comparing any results. Prevalences might vary by a 
factor 2 to 3 depending on the method that is used. Haematocrit values should also be 
systematically correlated with infection status as this is providing useful information on the 
impact of the disease in a specific area. Highly virulent parasites will strongly affect the PCV 
values of infected animals as opposed to more endemic situations where a better host/parasite 
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balance is observed. This distinction is essential for the establishment of a coherent control 
strategy. 
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5.1 Abstract 
African Animal Trypanosomosis is threatening the agricultural production and cattle breeding 
more severely than any other livestock disease in the continent, even more since the advent of 
drug resistance. A longitudinal study was conducted from November 2012 to May 2013 in 
Ghibe valley to evaluate diminazene aceturate (DA) resistance, follow infection dynamics of T. 
congolense after treatment and assess the livestock owner's perception of trypanocidal drug 
use. For blood sampling, four Peasant Associations (PAs) were purposively selected. At baseline, 
106 infected and 119 negative control animals were recruited for six months follow-up using 
HCT, 18S-PCR-RFLP and microsatellite analysis. In another 10 purposively selected PAs, a semi-
structured questionnaire was used to interview farmers about drug use. Prevalence of 
trypanosomosis was 18.1% based on the HCT technique and the mean PCV value was 
23.6±5.1% for the 587 sampled cattle. Out of the 106 HCT positive, 64 (60.4%) were positive for 
the presence of trypanosomes using the 18S-PCR-RFLP. Species detected by this method were 
38 (59.4%) T. congolense savannah, 18 (28.1%) T. vivax, 5 (7.8%) T. theileri and 3 (4.7%) T. 
congolense Kilifi. Among the T. congolense savannah samples, 31 (81.6%) showed a DA resistant 
RFLP profile, 2 (5.3%) a mixed profile and 5 did not amplify using the DpnII-PCR-RFLP. A positive 
HCT had a significant effect on PCV (P < 0.001) with the mean PCV value equal to 24.4±0.2% in 
the absence of trypanosomes and to 20.9± 0.3% in the presence of trypanosomes. PCV 
increased significantly (P < 0.001) with 4.4 ± 0.5% one month after treatment. All T. congolense 
savannah type were analysed using the microsatellite markers TCM1, TCM3 and TCM4 to follow 
the evolution of infection after treatment. The main events were new infections (40.0%) and 
relapses (37.5%) with cures lagging at 22.5%. From the questionnaire survey, the average herd 
size in Tropical Livestock Unit (TLU) was highest in Abelti PA (6.7±1.8) and a statistically 
significant difference (p=0.01) in the mean herd size in the 10 PAs.  Trypanosomosis was 
designated as the main disease affecting cattle by 97% of the respondents. DA was used by 
95.5% of the farmers though more than half of them (51.9%) were not familiar with 
isometamidium (ISM). There was a trend to overdose young small animals and to underdose 
large ones. Oxen were treated very frequently (nearly 20 times/year) and calves almost never. 
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To improve the situation in the Ghibe valley, extension packages should be delivered to 
promote a rational drug use, improved livestock management and the application of strategic 
vector control methods.  
 
Keywords: Trypanosoma congolense, 18S-PCR-RFLP, microsatellite, trypanosomes, PCV, 
Diminazene, cattle, Ghibe  
 
5.2 Introduction  
Livestock contributes significantly to the economy of developing countries. However, animal 
diseases including trypanosomosis are still major constraints to the livestock-sector productivity 
(Forman et al., 2012). African Animal Trypanosomosis (AAT) is a disease transmitted biologically 
by tsetse and mechanically by various hematophagous biting flies like stomoxes or tabanids. 
The disease causes morbidity and mortality in wide geographic areas estimated to 9 million km2 
across Africa (Jahnke et al., 1988). This insect-borne disease is caused by kinetoplastid protozoa 
and affects most species of domestic livestock and wild animals. (Getachew, 2005; Osório et al., 
2008). AAT has been listed among the neglected tropical diseases affecting marginalized 
populations (FAO, 2002). Moreover, AAT afflicts the poorest and remotest populations with 
limited or no access to veterinary health services. It is threatening the agricultural production 
and cattle breeding more severely than any other livestock disease in the continent (Getachew, 
2005; Pagabeleguem et al., 2012; WHO, 2012). 
 
With a population now exceeding 80 million, Ethiopia is the second most populated country in 
Africa after Nigeria. Most Ethiopians live in highland areas, with 85% of the population being 
rural and relying on low productivity agriculture. The ever increasing population pressure in 
those highland areas has led to an expansion of agriculture to more marginal zones (Awulachew 
et al., 2007) which are potentially productive but tsetse infested (Getachew, 2005; Reid et al., 
2000). To help people to survive in these marginal areas, trypanosomosis control activities have 
been successfully implemented: (i) in the Ghibe valley using ‘pour-on’ insecticides (Leak et al., 
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1995; Rowlands et al., 2000), (ii) in Didessa valley using community based odour-baited, 
insecticide impregnated target/trap technology as part of the Eastern African Regional 
Programme and, finally (iii) in the southern Rift valley, the eradication of the flies using the 
sterile insect technique (Getachew, 2005). However, due to the lack of natural barriers and to 
the non-sustained control efforts, flies reinvade the tsetse-cleared territories. Thus, farmers still 
rely on chemotherapy and chemoprohylaxis to maintain their livestock in acceptable health 
condition. Unfortunately, treatment failures and chemoresistance against the existing 
trypanocidal drugs have also been reported (Codjia et al., 1993; Moti et al., 2012; Mulugeta et 
al., 1997; Peregrine et al., 1997; Tewelde et al., 2004).  
 
The way chemotherapy and chemoprophylaxis is performed in the field and its efficacy depends 
on multiple factors such as farming type, herd size and structure, breed, knowledge of the 
disease, availability of veterinary services and drugs and legislation about drug administration. 
Those parameters can fairly be evaluated by standardized questionnaires. In addition, 
molecular techniques like microsatellite loci length analysis allows population genetics and 
phylogenetic analysis (Duvallet et al., 1999; Morrison et al., 2009) but also to gain better insight 
in the infection dynamics of trypanosomosis. Most of the papers on AAT differentiate between 
infected and uninfected animals (Abebe and Wolde, 2010; Cherenet et al., 2004; Kebede and 
Animut, 2009; Leak et al., 1993; Mekuria and Gadissa, 2011; Mulugeta et al., 1997; Rowlands et 
al., 2001, 1993; Sinshaw et al., 2006; Tafese et al., 2012) but do not follow the infection status 
of a specific animal over time. The evolution of an infection after a treatment can be a cure or a 
“relapse”. However, a relapse can be the result of different events i.e. (i) the parasite was not 
killed by the treatment, (ii) the parasite was killed but a new infection occurred and (iii) the 
parasite was not killed and a new infection occurred by one or several strains. When setting up 
this study, our overall objective was to gain a more precise perspective of the drug resistance 
by examining it from a dynamic point of view and to link farmer's practices to the 
chemoresistance situation. The specific objectives of this study were (i) to evaluate diminazene 
aceturate (DA) resistance with the DpnII-PCR-RFLP assay, (ii) to follow the evolution after 
treatment of T. congolense savannah infection using microsatellite loci analysis and (iii) to 
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assess the agro-pastoral Knowledge, Attitudes and Practices (KAP) of livestock owners in the 
Ghibe valley, Ethiopia. 
 
5.3 Materials and Methods  
5.3.1 Study site description  
The present study was conducted in the Ghibe valley area which is located at about 180 km 
southwest of Addis Ababa. The mean annual rainfall hardly reaches 900 mm. The mean 
monthly temperature ranges from 29.8 to 44.0⁰C (Rowlands et al., 2001). Agriculture is mainly 
based on a small-scale mixed crop-livestock production with little financial input. Cattle are 
used as draught power and as an alternative banking system. Mechanization of the farming 
activities concerns only a few larger exploitations. The study site and the peasant associations 
(PAs) were selected on the ground of a previous cross-sectional study (Moti et al., 2012). The 
landscape is topographically heterogeneous, consisting of upper plateaus (1400-1800 m 
elevation) separated by deep gorges of the Gilgel Ghibe and Ghibe Rivers (Reid et al., 2000). 
The intense agricultural expansion is thinning out the forest and natural vegetation coverage. 
These changes in land use and cover is a direct consequence of trypanosomosis control and 
prevention (Reid et al., 2000).  
 
5.3.2 Longitudinal study  
5.3.2.1 Study animals 
The cattle included in this study were all of zebu breed and classified as calves (< 1 year), young 
adults (1-4 years), and adults (> 4 years), including cows, bulls and oxen. Three classes of body 
conditions were considered i.e. lean, medium and fat (Nicholson and Butterworth, 1986). 
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5.3.2.2 Sampling strategy and sample size  
This study was conducted from November 2012 to May 2013. Four PA’s were purposively 
selected (ease of access and proximity of suitable tsetse habitat according to expert opinion): 
Yatu, Keta Wabe, Keta Bosso and Boke (Figure 5.1). 
 
During the first two visits, the peasants were requested to gather their cattle at one site where 
they were purposively selected (the closest animal at the moment of blood taking). The 
haematocrit centrifugation technique (HCT) was used to detect trypanosome infections in the 
animals.  
 
To recruit a group of 106 positive animals, a total of 587 cattle were bled. The 106 positive and 
119 negative control animals were recruited and ear-tagged (Figure 5.2). The remaining 362 
negative cattle were not further followed up. The selected animals were visited monthly for a 
period of six months. During each sampling, blood samples were collected for HCT on the spot 
and aliquots were preserved for further molecular analysis. In between the monthly visits, 
farmers were asked to report any acutely sick animal to the local development agent who was 
responsible for veterinary assistance and had to report any treatment. 
 
5.3.2.3 Ethical consideration  
The experimental protocol and sampling were approved by the Ethical Committee of Jimma 
University and the Zonal Agricultural Bureau. The background of the study was explained to the 
PA’s and consent of the farmers was asked for sampling of their animals.  
 
5.3.2.4 Blood collection 
Two ml of blood was collected from the jugular vein in EDTA treated BD Vacutainer® tubes 
(Becton-Dickinson, USA) for parasitological examination. About 0.75 ml was preserved in an 
equal volume of saturated 6 M guanidine buffer for further molecular analysis. 
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As an incentive, antibiotics, acaricides and anthelmintics were provided for the treatment of 
sick animals. In addition, minor surgical operations and advice on animal husbandry were 
provided for free. 
 
5.3.2.5 Haematocrit Centrifugation Technique 
Blood from the EDTA treated BD Vacutainer® tubes (Becton-Dickinson, USA) was collected in 
microhaematocrit capillary tubes and sealed on one end with Cristaseal® (Hawksley). The 
capillary tubes were centrifuged at 15, 000 rpm for 5 minutes and then placed in a Woo viewing 
chamber. The leukocyte - plasma interface was examined for the presence of trypanosomes 
(Woo, 1970). The packed cell volume (PCV) was measured and values below 24% were 
considered as anaemia (Marcotty et al., 2008; Van den Bossche and Rowlands, 2001). 
 
Cattle found positive for any species of pathogenic trypanosome with a PCV lower or equal to 
18% and negative cattle with a PCV lower or equal to 18% were treated with 3.5 mg diminazene 
aceturate (DA) /kg B.W. (Veriben®, CEVA Santé Animale, France). Any animal relapsing after 
treatment with 3.5 mg DA/kg B.W. was treated with the double dose. Any animal relapsing 
after administration of this double dose was treated with 0.5 mg isometamidium chloride (ISM) 
/kg B.W. (Veridium®, CEVA Santé Animale, France). 
 
5.3.2.6 Molecular Assays 
5.3.2.6.1 DNA extraction and 18S-PCR-RFLP screening 
For the 106 HCT positive cattle, DNA was extracted from 200μl of the mixture blood/guanidine 
buffer using the commercial kit QIAamp® DNA Blood Mini kit (Quiagen Inc, Valencia, USA). For 
trypanosome species confirmation, DNA amplifications were done using three primers targeting 
the gene coding for the small ribosomal subunit 18S (semi-nested PCR) and followed by 
digestion of the amplicons using Msp1 and Eco571 enzymes (New England BioLabs, USA) as 
described by Geysen et al. (2003). 
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5.3.2.6.2  Diminazene aceturate DpnII-PCR-RFLP resistance test 
All T. congolense positive samples (based on 18S-PCR-RFLP) were amplified using two primers 
targeting the P1-type purine transporter TcoNT10 gene. The accession number of TcoNT10 
gene is TcIL3000_9_2500 (http://www.genedb.org). Then, the PCR products were digested by 
DpnII restriction enzyme for DA resistance determination (Delespaux and de Koning, 2013; 
Delespaux et al., 2006; Munday et al., 2013; Vitouley et al., 2011). 
 
5.3.2.6.3  Microsatellite loci analysis of T. congolense samples 
Five species specific polymorphic microsatellite markers TCM1, TCM2, TCM3, TCM4 and TCM7 
(Morrison et al., 2009) were considered in the analysis of the T. congolense samples. Briefly, 
Morrison et al. (2009) identified these markers by screening of T. congolense genome sequence 
with the Tandem Repeat Finder software, which resulted in the identification of 4500 loci 
containing repeats. Selected 25 candidate microsatellite loci were tested initially against a 
reference panel of T. congolense isolates to determine the level of polymorphism and potential 
sub-group specificity and against T. brucei and T. vivax genomic DNA to ensure species-
specificity. In our study, the 6-FAM-labeled PCR products using TCM1, TCM3 and TCM4 were 
sent to GenoScreen (http://www.genoscreen.fr/, Campus de l’Institut Pasteur de Lille, 59000 
Lille Cedex, France) for length determination by capillary electrophoresis. Animals were only 
considered if data were available for at least two observation points for one single 
microsatellite locus (Annex 1). For estimating possible events, the binomes values (allele 1 and 
2 of the available loci) were considered at two observation points T1 and T2. The same values at 
T1 and T2 were considered as a relapse, any new value at T2 as a new infection and any value 
disappearing at T2 as a cured infection.  
 
5.3.3 Questionnaire Survey 
A semi-structured questionnaire was adapted from Van den Bossche et al. (2000). Interviewers 
were trained on data collection and the questionnaire was pre-tested with colleagues before 
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use in 10 purposively selected PA’s with the following inclusion criteria (i) ease of access, (ii) 
similarity in agro-ecological characteristics and (iii) trypanosomosis prevalence. The 10 selected 
PA's were situated in the Jimma, Gurage and West Shoa Zone (Figure 5.1). The average cattle 
herd sizes were compared following conversion to tropical livestock units (TLU) at a conversion 
rate of 1 for bulls, 0.7 for cows, 0.5 for weaned calves and 0.2 for suckling calves (Machila et al., 
2003). Among those 10 PA’s, four of them were considered for the longitudinal study. From 
each PA, about 15 farmers were randomly selected for a total of 156 interviewees. The 
questionnaire included questions on socio-economic parameters and on knowledge, attitude 
and practice in trypanocidal drug use. 
 
5.3.4 Statistical analysis 
The association between disease prevalence and anaemia, age, sex and study site was 
investigated by the chi square test at the 5% significance level. 
 
The difference in PCV was tested between the group of animals infected at the beginning of the 
study (t0) and control animals. First, PCV at t0 was compared between the two groups using a 
fixed effects model with group as fixed effects factor. Next, the PCV profile over time was 
compared between the two groups using a mixed model with time, group and their interaction 
as categorical fixed effects and animal as random effect. 
 
In order to assess the relationship between the presence of trypanosomes (HCT) and PCV 
throughout the whole study, a mixed model was fitted with HCT as categorical fixed effect and 
animal as random effect. 
 
In order to assess the treatment effect, the PCV change after treatment, i.e., the difference in 
PCV between the month after the treatment and the month when the treatment was given is 
used as a response variable in a mixed model with treatment as categorical fixed effect and 
animal as random effect. 
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Data generated from questionnaire survey were analyzed using descriptive statistics like means, 
frequencies and percentages for different parameters. All analyses were made using Statistical 
Package for Social Sciences (SPSS) version 16 software. 
 
5.4 Results 
5.4.1 Prevalence and diminazene aceturate resistance 
Based on the HCT technique, the prevalence of trypanosomosis at t0 was 18.1 % (n=106). Details 
per species are provided in table 5.1.  
 
Table 5.1 Infection rate per species of trypanosomes (HCT for the 587 animals of the study) in 
the Ghibe valley 
Species diagnosed  Positives Infection rate (%) 
T. vivax 13 2.2 
T. congolense 54 9.2 
T. brucei 3 0.5 
T.v + T.c 26 4.4 
T.v + T.b 2 0.3 
T.c + T.b 8 1.4 
Total 106 18.1 
T.v:T. vivax, T.c: T. congolense, T.b: T. brucei 
 
The mean PCV value and standard error was 23.6±5.1% with a range between 9 and 36%. 
Almost half of the animals (47.9%) had a PCV value below 24% (anaemic) and being anaemic 
was significantly associated (P < 0.01) with the presence of trypanosomes. Infection rates varied 
significantly (p < 0.05) between study sites, body conditions and sexes (Table 5.2). 
 
At t0, out of the 106 trypanosome HCT-positive blood samples, 64 (60.4%) were positive for the 
presence of trypanosomes using the 18S-PCR-RFLP. Species detected were 38 (59.4%) T. 
congolense savannah, 18 (28.1%) T. vivax, 5 (7.8%) T. theileri and 3 (4.7%) T. congolense Kilifi. 
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Table 5.2 Association of trypanosomosis in the Ghibe valley with study sites, age, sex and body 
condition  
Variable Categories  Total sampled Number 
positive (%) 
p-value 
 
 
Study site 
Yatu  120 10 (8.3)  
 
P ≤ 0.001 
Keta Bosso 129 15 (11.6) 
Boke  235 56 (23.8) 
Keta Wabe 103 25 (24.3) 
 
 
Age 
Calf 29 10 (34.5)  
 
P = 0.06 
Young  100 16 (16.0) 
Adult 458 80 (17.5) 
 
Sex 
Male  370 81 (21.9)  
P = 0.002 Female  217 25 (11.5) 
 
 
Body condition 
Lean  124 32 (25.8)  
 
P = 0.02 
Medium 250 45 (18.0) 
Fat 213 29 (13.6) 
 
The 38 T. congolense savannah were screened for DA resistance with the DpnII-PCR-RFLP: 31 
(81.6%) showed a RFLP profile which may be linked to DA resistance, 2 (5.2%) a mixed profile 
and the remaining 5 (13.2%) did not amplify. The three T. congolense Kilifi gave a negative 
DpnII-PCR.  
 
5.4.2 Longitudinal study  
The PCV’s evolution in time for the two groups of animals (infected or negative at t0) is shown 
in Figure 5.3. The mean PCV value of the negative control animals (24.9 ± 0.5%) differed 
significantly from that of the infected animals (20.9 ± 0.5%) at the start of the study. The 
interaction between group and time was significant (P < 0.001), due to the fact that the PCV 
values of the two groups were coming closer together with time.  
 
At t0, the presence of trypanosomes (HCT) had a significant effect on PCV (P < 0.001) with the 
mean PCV value equal to 24.4± 0.2% in the absence of trypanosomes and to 20.9± 0.3% in the 
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presence of trypanosomes. PCV increased significantly (P < 0.001) with 4.4 ± 0.5% one month 
after treatment.  
 
Figure 5.3 PCV evolution for the two groups of animals (HCT negative or positive at t0) followed 
by longitudinal study in the Ghibe valley. Asterisk denotes a significant result between the two 
groups and the bars show the standard error.  
 
5.4.2.1 Microsatellite loci analysis (T.congolense savannah) 
Out of the five primer pairs, only three gave satisfactory amplification. TCM2 and TCM7 showed 
no detectable PCR product after gel electrophoresis. From the 38 samples that were confirmed 
by 18S-PCR-RFLP as T. congolense savannah type, microsatellite data are available for 35 of 
them (Annex 1). 
 
When an animal is positive after treatment, this can be due to different events: (i) a relapse, (ii) 
a new infection, (iii) or a combination of both. The distribution of the events is summarized in 
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table 5.3 and detailed information is available in Annex 2. Most of the events (70 - 80%) took 
place one or two months after treatment. New infections (40.0%) and relapses (37.5%) are the 
main events with cures lagging at 22.5%. 
 
Table 5.3 Microsatellite loci analysis results depicting infection events in cattle from the Ghibe 
valley as a function of the number of months after treatment  
Month(s) after 
treatment 
Number of relapses Number of new 
infections 
Number of cured 
infections 
1 15 11 8 
2 13 15 8 
3 1 4 2 
4 4 6 2 
 
5.4.3 Questionnaire survey  
5.4.3.1 Socio-economic status and herd composition profile 
The majority of the respondents (98.1%) were male and the mean age of the respondents was 
44.6±13.9 years ranging from 18 to 85 years. The family size ranged between 1 and 14 with an 
average of 5.9±2.3. The mean number of illiterate, grade 1-6, grade 6-12 and higher education 
per family of the respondents were 2.6±1, 2.8±1.6, 2.0±1.3 and 1.3±0.5, respectively. All 
interviewed farmers practice mixed farming (crop and livestock production) and for 99.4% of 
the respondents crop production contributes the most to the family income. The average cattle 
herd size expressed in TLU was the highest in Abelti PA (6.7±1.8) and all animals were of 
indigenous zebu breed (Table 5.4). There was a statistically significant difference (p=0.01) in 
mean cattle herd size between the different PA’s considered. Beside cattle, the vast majority of 
the interviewed farmers have also donkeys and oxen, 70.5 and 98.1%, respectively. Most of 
them also rely on poultry breeding. For the majority of the respondents (98.7%), 
trypanosomosis was designated as the main disease affecting their cattle.  
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Table 5.4 Average herd Tropical Livestock Unit (TLU) profiles of different PAs in the Ghibe valley 
Peasant 
associations 
Number 
interviewed  
Average herd TLU ± 
SD 
Minimum Maximum 
Yatu 15 5.16±4.7 1 20 
Serit and Agemsa 16 3.80±1.3 2 6 
Keta Bosso 15 4.06±1.7 2 7 
Legeboter 17 5.44±4.1 2 17 
Keta Wabe 15 5.66±1.7 2 8 
Boke 16 5.15±2.5 2 10 
Bilowayu 15 3.71±1.3 2 6 
Gerangera 16 3.92±2.3 2 10 
Abelti 15 6.56±1.8 4 10 
Kulit Hulet 16 3.62±1.1 2 6 
 
5.4.3.2 DA and ISM use 
DA was used by 95.5% of the farmers the year preceding this survey compared to 48.1% for 
ISM. The majority of the respondents (89.7%) treated their animals because they thought that 
the animals had trypanosomosis, but for ISM only 6.4% of the respondents used it for 
prevention and 37.8% for treatment of sick animals. The majority of the farmers (91.3%) used 
different doses of DA according to the different age categories, for ISM this percentage fell to 
46.8% and 51.9% of them didn’t use the drug at all. There was a trend to overdose young small 
animals and to under-dose large ones (Table 5.5).  
 
Oxen are treated frequently (nearly 20 times/year), calve almost never and cows/bulls are 
situated in between (Table 5.6). In 66% of the cases, farmers are treating their animals by 
themselves (Table 5.5). The average number of DA sachets used per herd/year was 26.1±16.4 
ranging from 3 to 83 sachets. The average number of ISM sachets used per herd/year was 
2.1±1.4 ranging from 1 to 6 sachets. 
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Table 5.5 Different practices of DA and ISM use by farmers in the Ghibe valley  
Drug use Practices  DA – % of 
farmers 
ISM – % of farmers 
Use of the trypanocide  95.5 48.1 
In order to treat trypanosomosis  89.7 37.8 
Same dose administered to all age categories 3.2 1.3 
 
Dose calves (0-1 year) 
Dosing correctly 0.6 - 
Under dosing 0.6 - 
Over dosing 86.5 47.4 
 
Dose young cattle (1-4 years) 
Dosing correctly 5.1 - 
Under dosing - 0.6 
Over dosing 87.2 48.1 
 
Dose adult cattle (>4 years)  
Dosing correctly 93.6 7.7 
Under dosing - 40.4 
Over dosing - 0.6 
Dilute and keep left over of ISM - 0.6 
 
Treatment season  
Wet  7.9 19.9 
Dry  8.5 31.2 
Both 83.6 48.9 
 
Drug dilution medium  
Boiled water 13.6 
Well water 67.3 
 
Drug administration 
Farmer  66.7 
Veterinary 
assistant 
30.8 
 
5.5 Discussion 
5.5.1 Prevalence and resistance 
Trypanosomosis control and prevention by the Ethiopian government and non-governmental 
organizations in the Ghibe valley dates back to the second half of the 20th century (Rowlands et 
al., 1999). This control was supposed to significantly decrease the prevalence of the disease 
even though eradication was not achieved. However, our study revealed an important 
prevalence of 18.1% in the Ghibe river basin. This is higher than a prevalence of 12.1% reported 
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previously in the Metekel zone (Tesfaye et al., 2012) and of 10.1% in the Awi zone (Kebede and 
Animut, 2009) but it must be recalled that our study sites were purposively selected for their 
high tsetse challenge. 
 
Table 5.6 Reported DA and ISM treatments by farmers in the Ghibe valley  
Type of animal Treated 
using DA 
(%) 
Average number of DA 
treatments/animal/year 
Treated 
using ISM 
(%) 
Average number of ISM 
treatments/animal/year 
Calves (0-1yr) - - 1 (0.6) 2 
Young (1-4yr) 33 (21.2) 4.8±3.4 4 (2.6 ) 1.8±0.5 
Cows treated  96 (61.5) 7±5.6 47 (30.1) 4.2±3.2 
Bulls treated  51 (32.7) 6.9±4.7 21 (13.5) 3.3±2.2 
Oxen treated 145 (93) 19.4±11.8 69 (44.2) 8.1±6.4 
 
 
Despite the intensive agricultural expansion in the locality leading to fragmentation of suitable 
tsetse habitat and the intensive trypanocidal drug use, trypanosomosis prevalence remains high 
in the Ghibe valley. Two factors are likely to contribute to this situation. Firstly, drug resistance 
in the region that was already reported by other groups (Codjia et al., 1993; Moti et al., 2012; 
Rowlands et al., 1993) and confirmed by our DpnII-PCR-RFLP and microsatellite analysis 
(numerous relapses after treatment). Secondly, even though the tsetse habitat is becoming 
highly fragmented, cattle gets easily in contact with the vector at watering points, especially in 
the dry season when flies are clustering around unspoiled river banks. 
 
Based upon a strong statistical correlation that was demonstrated between the DpnII-PCR-RFLP 
and the DA-resistant phenotype (Chitanga et al., 2011; Delespaux et al., 2008, 2006; 
Mamoudou et al., 2008; Moti et al., 2012), this test remains a reliable read-out for DA-
resistance although Munday et al. (2013) showed that the target gene in this test codes for a 
P1-type purine transporter not directly involved in DA transport. 
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5.5.2 Longitudinal study  
Anaemia is one of the classical clinical signs of trypanosomosis (Van den Bossche and Rowlands, 
2001) and an inverse correlation between the PCV’s value and the presence of trypanosomes is 
often observed (Rowlands et al., 2001). In our study, the average PCV value of infected animals 
was, as expected, significantly lower than those of the HCT negative controls for the first two 
months of follow up. 
 
No significant difference in PCV was observed during the last four months of observation 
between t0 negative and positive group. Indeed, the treatment of any positive animal in both 
groups is explaining why PCV values converge. Even if DA resistance is present, the effect of 
treatment on the PCV is still observable. This phenomenon was previously observed in cattle 
and goats inoculated with drug resistant trypanosomes and treated with trypanocidal drugs 
(Delespaux et al., 2010; Vitouley et al., 2012). 
 
In the publication of Morrison et al. (2009), seven microsatellite loci were used. However, we 
were not able to reproduce their results with our samples from the Ghibe valley. The nested 
PCR was creating some strong artefacts (results not shown). Therefore, we worked with a single 
run and lost sensitivity. Our data was scantier than expected, with only three loci that amplified 
properly. However, some conclusions can be drawn. Most of the events (relapse, new infection 
or cure) were observed during the first two months of follow up. In other words, the probability 
for an animal to remain free of parasites for more than two months was low. Relapses and new 
infections constituting, in similar proportion, about 80% of the events indicates that the tsetse 
challenge is high and drug resistance is present to a large extent. 
 
5.5.3 Questionnaire survey 
Most of the farmers had donkeys and oxen showing the importance of the animal traction in 
the area. Besides crop production, most of the farmers also relied on poultry (short cycle 
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species for meat production) for quick cash money availability allowing a.o. the purchase of 
trypanocidal treatments. 
 
DA was more popular among the farmers compared to ISM. Livestock keepers are focusing on 
sick animals and do not think in terms of prophylaxis. The multi-dose packaging of ISM is a 
limiting factor. With a mean herd size of around 6, the unused diluted ISM is more a constraint 
than an advantage. Treatments were definitely focused on the most valuable animals i.e. those 
used for transport or ploughing. This is in agreement with the observations of Van den Bossche 
et al. (2000) in Eastern Zambia. The high frequency of treatment of those productive animals is 
certainly one of the factors explaining the chemoresistance in the area. 
 
The majority of the farmers used water straight from a well for dilution and administered the 
treatment themselves. The use of unsterilized water might cause of abscesses after injection. 
Those abscesses are sequestering the drug and lead to lower drug serum concentration and 
might lead to poor drug efficacy, therapy failure and possible drug resistance. This result is in 
agreement with the reports of other research groups (Tesfaye et al., 2012; Van den Bossche et 
al., 2000).  
 
5.6 Conclusions and implications 
The situation in the Ghibe valley could be summarized as follows: (i) the tsetse challenge 
remains high despite habitat fragmentation, (ii) the trypanosomosis prevalence remains high, 
(iii) drug resistance is present in the area, (iv) veterinary services are scanty, (v) knowledge of 
the farmers about drug use is low and (vi) many trypanocidal drugs brands from all continents 
are available from local shops and markets. 
 
Solutions to improve the situation include the delivery of extension packages to promote a 
rational drug use (appropriate drug quality, correct dilution, right dose, and focus on clinical 
cases) and to improve the livestock management (appropriate feeding, strategic deworming). 
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As drug resistance is a reality in the area, strategic vector control should be promoted such as 
insecticidal spraying of the herds with permethrin or derivates. Years of national efforts for 
controlling the tsetse fly in Ethiopia have brought some temporary relief to the farmers but flies 
rapidly reinvade cleared areas. If the budget of the government allows it, then this effort should 
be continued and extended to areas that are not benefiting from it. The alternative for the 
farmers is to become self-sustainable but this requires knowledge and efforts. Awaiting for a 
potential eradication of the tsetse fly, if ever achieved, the EU funded project Trypanosomosis 
Rational Chemotherapy (TRYRAC) (http://www.trypanocide.eu/) is meanwhile promoting a self-
sustainable alternative which is a solution when national programmes for vector control are not 
implemented.  
 
The last recommendation would be to test the quality of the drugs that are circulating in the 
area. This is now possible since two African laboratories were equipped for this purpose as part 
of a FAO - Galvmed initiative namely the Laboratoire de Contrôle des Médicaments Vétérinaires 
(LACOMEV) in Dakar and the Tanzania Food and Drug Authority (TFDA) Quality Control 
Laboratory in Dar es Salaam. Those two laboratories are performing standardised tests upon 
internationally agreed quality standards. 
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ANNEX 1. Summary of longitudinal follow up of the microsatellite markers used for analysis of 
T. congolense samples from the Ghibe valley 
 November December January March April May 
Ani
mal 
ID 
TC
M
1 
TC
M
3 
TC
M
4 
TC
M
1 
TC
M
3 
TC
M
4 
TC
M
1 
TC
M
3 
TC
M
4 
TC
M
1 
TC
M
3 
TC
M
4 
TC
M
1 
TC
M
3 
TC
M
4 
TC
M
1 
TC
M
3 
TC
M
4 
77  + +        + +       
236  +   +              
239        + +  +        
241        + +  +        
247        + +  + +     +  
252 + +      + +  +        
267 + + +     + +          
268  + +     + +  +        
269 + + +  +              
270 + +        + + +       
271    + +   +  + + +       
274       + + + + + +       
283 + +        + + + + +     
285 + +         + +    + +  
289    + + + + +   +        
298 + +         +        
310             + +  +   
311  +  + + +    + + + + +     
318  +           + +     
331        +   +        
332 + + +  +      +        
333    + + + + + + + +        
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339        + + + + + + +     
365    + +   +           
373       + + + + + +       
381           +  +   + +  
429 + +        + + +       
542    + +     + + +       
543    + + +  + +    + +  + +  
544           +     + +  
554    + + + +    +        
561     +   +           
570             + +  + +  
574          + + + + + + +   
586     +   + +          
TCM=T. congolense microsatellite marker  
With + as microsatellite data available for the animal at an observation moment 
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ANNEX 2: Details of the T. congolense samples from the Ghibe valley analysed using three 
microsatellite markers and size of the alleles at each microsatellite locus  
Month and 
animal ID Locus 
Allele 
size 1 
Allele 
size 2 
Allele 
size 3 
Allele 
size 4 
Allele 
size 5 Events 
Months 
post 
treatment 
November 77 TCM3 182 184 NI 4 
November 77 TCM4 157 160 
March 77 TCM3 190 193 
March 77 TCM4 157 160           
November 236 TCM3 190 190 R+NI 1 
December 236 TCM3 182 190 193         
January 239 TCM3 184 193 2 NI 2 
March 239 TCM3 172 184 190         
January 241 TCM3 190 193 R 2 
March 241 TCM3 190 193           
January 247 TCM3 182 190       R 2 
March 247 TCM3 182 190 TR+R+NI 2 
May 247 TCM3 190 193           
November 252 TCM3 182 182       NI 2 
January 252 TCM3 184 193 R+NI 2 
March 252 TCM3 184 190 193         
November 267 TCM3 182 190       R+NI 2 
November 267 TCM4 157 157 
January 267 TCM3 182 182 
January 267 TCM4 157 160           
November 268 TCM3 190 193       NI 2 
November 268 TCM4 157 157 
January 268 TCM3 172 184 
January 268 TCM4 157 160 TR+R+NI 2 
March 268 TCM3 182 184 190         
November 270 TCM1 171 181       TR+R+NI 4 
November 270 TCM3 182 184 190 193 
March 270 TCM1 171 179 
March 270 TCM3 190 193           
December 271 TCM3 190 190       
December 271 TCM1 171 171 R+NI 1 
January 271 TCM3 184 190 TR+R+NI 2 
March 271 TCM1 171 179 
March 271 TCM3 184 193           
January 274 TCM1 177 177       TR+R+NI 2 
January 274 TCM3 172 184 
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January 274 TCM4 157 160 
March 274 TCM1 171 177 
March 274 TCM3 172 182 184 190 193 
March 274 TCM4 157 160           
November 283 TCM1 171 171       R+NI 4 
November 283 TCM3 182 190 
March 283 TCM1 171 177 
March 283 TCM3 172 182 184 190 193 
April 283 TCM1 171 177 TR+R 1 
April 283 TCM3 172 184           
November 285 TCM3 182 190       TR+R+NI 4 
March 285 TCM3 172 184 190 TR+R 2 
May 285 TCM3 190 190           
December 289 TCM1 171 171       TR+R+NI 1 
December 289 TCM3 182 190 
January 289 TCM1 157 161 171 177 
January 289 TCM3 190 190           
November 298 TCM3 190 193       NI 4 
March 298 TCM3 182 184           
November 311 TCM3 190 193       R 1 
December 311 TCM1 179 183 
December 311 TCM3 190 193 
December 311 TCM4 157 160 TR+NI 3 
March 311 TCM1 171 171 TR+NI 1 
March 311 TCM3 184 190 
March 311 TCM4 157 157 
April 311 TCM1 179 183 
April 311 TCM3 190 193           
November 318 TCM3 184 193       R 4 
April 318 TCM3 184 193           
November 332 TCM3 172 184       NI 1 
December 332 TCM3 190 190 R+NI 3 
March 332 TCM3 172 182 184 190 193     
December 333 TCM1 171 171       R 1 
December 333 TCM3 190 190 
December 333 TCM4 205 207 
January 333 TCM1 171 171 
January 333 TCM3 190 190 
January 333 TCM4 157 240 R+NI 2 
March 333 TCM1 171 171 
March 333 TCM3 182 190           
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January 331 TCM3 190 193       TR+R+NI 2 
March 331 TCM3 182 190           
January 339 TCM3 182 184       NI 2 
January 339 TCM4 157 160 
March 339 TCM1 171 183 R+NI 1 
March 339 TCM3 190 193 
March 339 TCM4 233 236 
April 339 TCM1 171 171 
April 339 TCM3 182 190           
December 365 TCM1 171 171       R 1 
December 365 TCM3 190 190 
January 365 TCM3 190 190           
January 373 TCM1 171 171       R 2 
January 373 TCM3 182 190 
January 373 TCM4 157 157 
March 373 TCM1 171 171 
March 373 TCM3 182 190 
March 373 TCM4 157 157           
March 381 TCM3 184 190       TR+R+NI 2 
April 381 TCM1 171 183 R 1 
May 381 TCM1 171 183 
May 381 TCM3 184 193           
November 429 TCM1 171 171       NI 4 
November 429 TCM3 182 182 
March 429 TCM1 171 171 
March 429 TCM3 190 190     
December 542 TCM1 171 181       TR+NI 3 
December 542 TCM3 182 190 
March 542 TCM1 171 171 
March 542 TCM3 184 184     
December 543 TCM1 171 179       R 1 
December 543 TCM3 190 193 
January 543 TCM3 190 193 NI 3 
April 543 TCM1 177 177 TR+NI 1 
April 543 TCM3 172 184 
May 543 TCM1 171 179 
May 543 TCM3 190 193           
March 544 TCM1 190 190       TR+NI 2 
March 554 TCM3 172 184 
May 544 TCM1 171 181 
May 544 TCM3 182 190           
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December 554 TCM1 171 177 R 1 
January 554 TCM1 171 177           
December 561 TCM3 182 182       TR+NI 1 
January 561 TCM3 172 184           
April 570 TCM1 177 177       R+NI 1 
April 570 TCM3 172 184 
May 570 TCM1 177 179 
May 570 TCM3 172 184           
March 574 TCM1 171 179 183     TR+R+NI 1 
March 574 TCM3 190 193 
March 574 TCM4 157 160 
April 574 TCM1 179 183 
April 574 TCM3 190 193 
April 574 TCM4 157 160           
December 586 TCM3 182 184       TR+NI 1 
January 586 TCM3 172 184           
November 269 TCM3 182 190 193 TR+R 1 
December 269 TCM3 190 190           
April 310 TCM1 171 177       R 1 
May 310 TCM1 171 177           
Legend: R=relapse, NI=new infection, TR=effectively treated 
 
  
 
 
 
 
 
 
 
 
 
 
Chapter 6  
General discussion and future perspectives  
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 6  
139 
 
6.1 General Discussion 
The trypanosomosis burden in the Ghibe valley, Southwestern Ethiopia, remains high, despite 
the long and continuous efforts that have been undertaken in the region to control the disease. 
The research presented in this dissertation addresses the trypanosomosis problem sequentially 
as follows.  
i. What is the prevalence/incidence of trypanosomosis in the Ghibe valley, Southwestern 
Ethiopia, and which trypanosome species are contributing most to the burden?  
ii. What is the magnitude of DA and ISM resistance in the area? 
iii. What is the perception/knowledge of the farmers on trypanocidal drugs, and how does 
it impact on the trypanosomosis burden generally and on the drug resistance problem 
specifically? 
iv. Based on the insight gained on the trypanosomosis burden in the Ghibe valley, what 
strategy could be recommended for control.   
 
6.1.1 High prevalence of T. congolense savannah infections in the Ghibe river basin  
The majority of T. congolense strains identified using the 18S-PCR-RFLP belonged to the 
savannah subgroup. Three (2.8%) strains belonging to the Kilifi subgroup were also identified 
during the longitudinal study. Three different subgroups of T. congolense have been described 
so far, i.e., the savannah, Kilifi and forest (OIE, 2013; Rodrigues et al., 2014). This has an 
implication in the disease epidemiology since the pathogenicity among those different T. 
congolense subgroups and even within the savannah subgroup greatly varies (Van den Bossche 
et al., 2011). Moreover, besides pathogenicity, Rodrigues et al. (2014) showed that they also 
differ in resistance to drugs, vector species and geographical distribution. Bengaly et al. (2002) 
reported more severe symptoms and consistently higher levels of parasitaemia, lower 
haematocrit and lower leukocyte counts in the savannah-type infection compared to the other 
two types. 
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Different diagnostic tests exist for the detection of trypanosomes, and for the classification in 
the different subgroups. The specificity and sensitivity of such diagnostic tests are crucial in 
epidemiological studies in order to draw a correct conclusion. Therefore, part of the work was 
devoted to the evaluation of different sampling strategies and tests. In brief, samples were 
preserved in two different ways and the conventional microscopy test; HCT and PCR-RFLP were 
compared for the identification of trypanosomes. PCR using larger volume of blood in a 
protection buffer for DNA extraction, detected more positive cases than buffy coat samples on 
filter paper. The percentage of samples positive for trypanosomes was increased by more than 
50% and 250% when using PCR-RFLP-fp and PCR-RFLP-pb, respectively as compared to HCT.  
 
For the trypanosome species identification, PCR-RFLP-pb was found to be more efficient for T. 
vivax whereas PCR-RFLP-fp detected more T. congolense. The discrepancies in detection of 
trypanosome by the three techniques (HCT, PCR-RFLP-fp, and PCR-RFLP-pb) may be explained 
by uneven distribution of the parasite in blood samples because of the low parasitaemia in field 
conditions. This assumption is very much in agreement with Cox et al. (2010) who tested the 
hypothesis that parasite DNA contained in a blood sample may be unevenly distributed or 
clustered when using FTA (Fast Technology for the Analysis of nucleic acids) cards, with the 
result that taking a single punch as a template for a PCR-based diagnostic test may result in a 
false negative result simply because that punch did not contain any parasite DNA. They further 
explained that the likelihood of any single punch giving a false-negative is inversely related to 
the parasitaemia (i.e. parasite density) in the host animal blood. Therefore, in order to decrease 
the probability of false negative results, rather than using a single punch, the examination of 
extra punches would give a more accurate estimation of the disease prevalence (Ahmed et al., 
2011; Cox et al., 2010). Likewise our study demonstrated that increasing the volume of whole 
blood sample in protection buffer improved the sensitivity of the PCR-RFLP assay compared to 
buffy coat spot sampling on filter paper. 
 
Given the ongoing control and prevention using chemotherapy and chemoprophylaxis, the 
need for reliable diagnostic tools is unquestionable to evaluate the disease burden. The 
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collection of appropriate samples in a suitable medium is also as vital as choosing the particular 
diagnostic tool. Sampling on filter paper seems to be the easiest method to collect blood 
samples for molecular diagnosis in field situation. Though the detection rate when using the 
buffer solution was found higher, it demands more logistics for sampling and special medium 
for storage of samples. Unfortunately, the molecular analysis of trypanosomosis still remains 
costly and time consuming and thus, farmers continue to use clinical diagnosis for immediate 
treatment of sick animals.  
 
The high prevalence of T. congolense savannah in the cattle of the Ghibe might seem 
astonishing at first sight. Indeed, as Van den Bossche et al. (2010) explained, the anthropogenic 
environmental changes have important repercussions on the level of interaction between 
tsetse and cattle and, hence on the distribution, epidemiology and socio-economic impact of 
bovine trypanosomosis. In the Ghibe, a re-settlement program was launched for people 
starving in the North of the country (Getachew, 2005; Lemecha et al., 2006). This demands 
huge surfaces of land for agriculture to produce crops. It resulted in a high degradation and 
fragmentation of the tsetse habitat which logically should have reduced the fly pressure. 
However, flies are persisting along the remaining unspoiled river banks and can feed easily on 
cattle, especially at the end of the dry season when cattle are gathered at strategic watering 
points. Furthermore, as reported by Akoda et al. (2009), nutritional stress is increasing the 
susceptibility of the vector to the trypanosomes. The lower host availability might be 
compensated by a higher susceptibility of the vector. A second explanation of this high 
trypanosomosis prevalence, is the development of drug resistance. Indeed irrational drug use 
for both chemotherapy and chemoprophylaxis is the rule in the Ghibe valley. In those 
trypanosomosis endemic areas, farmers treat their cattle intensively to benefit of the draft 
power for agriculture. Since their treatment is not based on scientific knowledge and sound 
clinical evaluation, over-usage and under-dosage are key factors leading to trypanocidal drug 
resistance (Grace, 2003).  
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6.1.2 The magnitude of DA and ISM resistance in the Ghibe valley, South-western Ethiopia 
The chemo-resistance of the isolated trypanosomes was confirmed using in vivo tests in mice, 
PCR-RFLP and microsatellite analysis. Briefly, all isolates were found resistant to DA and ISM at 
all doses in the mice model. The same isolates turned-out to be resistant to DA using DpnII-PCR-
RFLP. Field samples from the same area (without isolation in mice) confirmed the high level of 
resistance in the area with 94.6% of resistant profiles, 2.7% of sensitive profiles and 2.7% of 
mixed profiles. In addition, at the baseline survey of the longitudinal study DpnII-PCR-RFLP 
revealed 81.6% of resistant profiles and 5.3% of mixed profiles. No sensitive profile was 
observed.  
 
Our resistance report is also supported by the microsatellite analysis allowing differentiation 
between clearance of infection, relapse or new infection after administration of the treatment. 
Although more new infections were found, the substantial number of relapses documented 
confirms the presence of trypanocidal drug resistance. However, some areas of concern during 
our microsatellite analysis include (i) field blood samples were used for DNA extraction whereas 
other researchers used T. congolense isolated in mice which increased their DNA quality and (ii) 
four out of seven microsatellite primers that we used didn't result in the desired amplicons for 
the majority of our samples. The results obtained by Morrison et al. (2009) were not 
reproducible in our hands.   
 
Though different researchers reported the occurrence of DA and ISM resistance (Chaka and 
Abebe, 2003; Mulugeta et al., 1997; Tewelde et al., 2004) in Ethiopia , this is, to the best of our 
knowledge, the first confirmation of T. congolense DA resistance in the Ghibe valley of Ethiopia 
based on molecular technique. There are different in vivo and in vitro methods of detecting 
resistant trypanosomes (Eisler et al., 2001; Peregrine and Mamman, 1993) but the DpnII-PCR-
RFLP method employed here was found to be an easy and fast method of DA resistance 
diagnosis compared to the mice model. Thus, it can be applied in a wider region for mapping of 
DA resistance in endemic areas like the Ghibe valley in Ethiopia. 
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To avoid the use of laboratory animals, a molecular assay for ISM resistance diagnosis is 
needed. At present, no genetic marker for ISM resistance is available. Moreover, some studies 
infer that trypanosome stocks that are sensitive to recommended therapeutic doses in mouse 
would be equally sensitive to therapeutic doses in cattle. However, isolates that were found to 
be resistant in mouse test models might gave varying results in cattle (Joshua et al., 1995). For 
instance, T. congolense that was resistant to 14 mg/kg diminazene aceturate in cattle was 
successfully treated with 56 mg/kg in mice (Mbwambo et al., 1988). From this perspective, 
when ISM resistance is reported in the mice model, interpretation and dose extrapolation for 
cattle needs precaution.  
 
Evidently, the development of resistance to both DA and ISM has serious implications in the 
strategies to be followed to control trypanosomosis using chemotherapeutic and chemo-
prophylactic measures. Regular resistance reports play a critical role in making decisions on the 
existing control and prevention strategies. The sustainable use of trypanocidal drugs in the 
future has been said to face two threats, next to the resistance of the trypanosome. First, 
availability might not be guaranteed. Pharmaceutical companies have been reluctant to 
develop new drugs against trypanosomosis since the market is perceived to be unprofitable in 
view of the poverty of African farmers. Furthermore, companies are reluctant to maintain the 
production of existing drugs if this requires significant investment. Secondly, fake drugs are a 
growing international threat to both human and animal health (Geerts et al., 2001; Holmes, 
1997; Pecoul et al., 1999). Thus, integrated tsetse and trypanosomosis control measures are an 
absolute necessity to decrease the impact of this disease. 
 
6.1.3 Farmer’s perception/knowledge about trypanocidal drugs 
Sustainable use of currently available drugs is only possible through rational drug use practices. 
The existing situation of drug use is not regulated or coordinated at any level. To safeguard 
animal dependent agriculture of the poor community, trypanocidal drugs market chain and use 
need to be well regulated by responsible private and government stakeholders. 
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Livestock owners in Ghibe over- and misuse both DA and ISM to fight the disease. As 
trypanosomosis has been shown to be the major animal health problem in Ghibe, researchers 
in other regions also reported the same and revealed similar unwise use of trypanocidal drugs  
(Gechere et al., 2012; Machila et al., 2003; Van den Bossche et al., 2000). Obviously, these 
improper practices might be the reason for the occurrence of drug resistance (Eisler et al., 
1997; Geerts et al., 2001).  
 
Though limited by issues of resistance development, chemotherapy has been and is being 
fundamental to the control of African trypanosomosis (Alsford et al., 2013). The widespread 
occurrence of resistance necessitates regular monitoring and evaluation of any ongoing control 
and prevention methods. It has been suggested that privatization of veterinary services in 
Africa including Ethiopia has led to a situation where drug administration is in the hands of 
farmers or extension workers, who are unskilled in differential diagnosis and lack knowledge 
about appropriate drug use (Van den Bossche et al., 2000). Thus, judicious and/or strategic use 
of currently available trypanocidal drugs in trypanosomosis endemic areas like Ghibe valley 
should be possible to properly utilize draft animal power for agricultural practice and livestock 
farming. In addition, control of trypanosomosis is more effective when using an integrated 
approach than solely relying on chemotherapy. Community education interventions to improve 
the knowledge, attitude and practice of trypanocidal drug use by livestock owners through 
different media (radio, booklets and leaflets) need to be in place. This type of community 
education interventions has been implemented with smallholder farms in Kenya and reported 
to be successful (Machila et al., 2007).  
 
6.1.4  Recommendations for trypanosomosis control in the Ghibe valley, South-western 
Ethiopia 
In this study, despite the high level of drug resistance, PCV levels of animals improved due to 
treatment administered after proper diagnosis. It was clear that PCV of animals negative at 
baseline decreased during the course of follow-up months mainly due to new trypanosome 
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infections. In contrast, for animals positive at baseline, PCV improvement of about 4.4% was 
observed one month after treatment. This suggests that a better balance between the host and 
the parasite is created by chemotherapy, in favor of the host. In the absence of other diseases 
causing anaemia, the PCV value is a good indicator of trypanosome infection in animals 
(Biryomumaisho et al., 2013; Marcotty et al., 2008). This has been witnessed by a study 
conducted in Zambia where the average herd PCV decreased with increasing prevalence of 
trypanosomal infections (Van den Bossche and Rowlands, 2001). Marcotty et al. (2008) also 
reported that the presence of a trypanosomal infection significantly reduced the PCV, 
independently of the age and sex of the infected animal. Therefore, decisions to intervene and 
control trypanosomosis cannot be based solely on the presence of trypanosome infected 
animals but should be supported by an assessment of the impact of the infection on animal 
condition and, hence, animal production (Van den Bossche and Rowlands, 2001). Thus, should 
farmers continue treatment despite the prevailing drug resistance? The answer is yes, but not 
in the way they currently do.  
 
Given the high number of drug treatments in some groups of animals in the Ghibe valley and 
the fact that high a treatment frequency is one of the most important reasons for the 
development of drug resistance, it could be wise to reduce the treatment frequency. This could 
be achieved by more strategic and focused treatments. i.e. only animals with PCV lower than 
24% and/or with clinical signs of trypanosomosis.      
 
It was clear from our field observations that chemotherapy should not be the only method for 
trypanosomosis control and prevention. It has to be supplemented by other vector control 
strategies such as applying insecticide (deltamethrin) to cattle (pour-on insecticide application) 
(Shereni, 1990), impregnated targets and odour-baited traps (Vale, 1993; Vale et al., 1988). As 
an alternative, 'restricted application of insecticide' using strategic deltamethrin spraying (legs, 
belly, anal and genital region, bottom part of the neck and chest) in combination with other 
methods could be used as more efficient and cost-effective control of tsetse (Torr et al., 2007). 
In addition, farmers need to be educated about strategic use of trypanocidal drugs, and the art 
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of drug marketing should be shaped in such a way to promote rational drug use (Grace, 2003; 
Grace et al., 2006). Furthermore, it is worth mentioning that the choice of vector or parasite 
control options is influenced by multiple factors (Allsopp, 2001; Reid et al., 2000; Schofield and 
Kabayo, 2008) which needs to be considered before action. Moreover, the paper of Scoones 
(2014) examined 'the ongoing and long-running debates about vector and parasite control 
methods, tracing the histories and associated politics of each'.   
 
Finally, regular large-scale epidemiological studies on drug resistance and trypanosomosis are 
crucial in making the correct conclusions on existing control and prevention strategy. Based on 
these studies, mapping drug resistance hot spot areas shall help in application of focused 
control measure. Besides, information from this large scale epidemiological study can be used 
to provide advice to the government on re-settlement program for food security. Because this 
re-settlement program is one among the factors that catalyses the dynamics of host, parasite 
and environment interaction (Cottontail et al., 2009; Mattioli et al., 2004; Patz et al., 2004; 
Samdi et al., 2012; Van den Bossche et al., 2010).    
 
6.1.5 Conclusion  
DA resistant strains of T. congolense savannah circulate in cattle in and around Ghibe valley at 
high prevalence. Resistance of T. congolense savannah to DA using PCR-RFLP and microsatellite 
analysis was confirmed for the first time in Ethiopia. ISM resistance was also demonstrated 
using the mice model and thus, confirming the widespread occurrence of resistance in Ghibe. 
Farmers use available trypanocidal drugs without any scientific knowledge about control and 
prevention which worsens the drug resistance problem. It is time to provide farmers with 
adequate education on rational drug use. It is also important to continue active surveillance in 
animals to understand the dynamics of drug resistance in endemic areas like Ghibe valley. 
Furthermore, conducting large scale disease and socio-economic surveys helps to monitor 
ongoing control and prevention strategy and adapt them to the dynamic environment.  
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6.2 Future Perspectives  
1. As DA and ISM will continue to be used for chemotherapy and chemoprophylaxis, conducting 
epidemiological studies of trypanocidal drug resistance in different tsetse belts of Ethiopia is an 
immediate necessity. With a better understanding of the epidemiology and magnitude of drug 
resistance at the national level, investigation of factors contributing to development of 
resistance should follow. This would help to revise the ongoing control and prevention strategy 
for use in trypanosomosis endemic areas in Ethiopia. 
 
2. A strategy for the distribution and control of trypanocidal drugs from the top to the bottom-
line users should be developed in the near future. In general, veterinary drugs do not seem to 
be properly managed when considering the pharmaceutical guidelines in the country. For 
example, any business oriented person can dispense trypanocidal drugs to the needy people in 
the Ghibe valley region and in Ethiopia in general. Such issues can be addressed by advocating 
standard operating procedures, besides active community education and putting 
laws/directives in place. A farmer's guide (extension material) on efficient and effective use of 
trypanocidal drugs needs to be prepared and disseminated. 
 
3. Traditional trypanocidal drugs used by farmers should be scientifically validated. Although 
there are new drugs in the pipeline, investigation of indigenous treatment knowledge among 
livestock owners in trypanosomosis endemic areas like Ghibe valley might generate novel drugs 
and help solving the problem. 
 
4. During this study T. congolense from Ghibe was not satisfactorily characterized using 
microsatellite markers developed elsewhere for the same species. This brought the assumption 
that T. congolense originating from Ghibe might possess different sequences in the regions 
bordering the microsatellite loci. Thus, more focused research that involves designing 
oligonucleotide sequences for amplification of selected microsatellites for T. congolense 
deserves an immediate attention for further genotyping.  
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Trypanosomosis can affect various species of mammals but, from an economic point of view, 
tsetse-transmitted trypanosomosis is particularly important in cattle.  The disease is a serious 
constraint to livestock production in areas of the north and southwest Ethiopia below 2000 
meters above sea level. Similarly to other trypanosomosis endemic areas, trypanocidal drugs 
remain popular among farmers of the Ghibe Valley because they allow treatment of individual 
animals and they are relatively cheap and widely available. Unfortunately due to this 
widespread use of chemotherapy for control of trypanosomosis, drug resistance has been 
reported from different parts of Ethiopia raising several questions. Therefore the objectives of 
this thesis were i) to  review literature on trypanocidal drug resistance in East Africa ii) to assess 
the magnitude of diminazene aceturate (DA) and isometamidium (ISM) resistance in the Ghibe 
Valley  iii) to compare the haematocrit centrifugation technique (HCT) with PCR with different 
sample storage methods for the identification of trypanosome infection and type and iv) to 
assess the knowledge, attitude and practices of livestock owners towards trypanocidal drug 
use. 
 
The first chapter of this thesis is focused on describing the parasite, the vector and their 
interaction and the impact of the disease on the host. Control options are reviewed. 
The second chapter consists of a concise literature review on trypanocidal drug resistance and 
related problems in East African countries. 
The third chapter contains a description of the results of a cross-sectional study that was 
carried out to assess the prevalence of trypanosomosis in tsetse controlled and non-controlled 
areas and to evaluate DA resistance in T. congolense savannah type.  Therefore, the DpnII-PCR-
RFLP was used in parallel with the gold standard, i.e., the mice test. Twelve isolates were 
successfully characterized by both methods. All isolates were resistant to both drugs at all 
doses. The effects of tsetse control operations in the area are discussed.  
 
In the fourth chapter, a comparison is made between the trypanosome specific 18S-PCR-RFLP 
using samples stored either on Whatman filter papers (PCR-RFLP-fp) or in a commercial cell lysis 
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and DNA protecting buffer (PCR-RFLP-pb) with the haematocrit centrifugation technique. The 
PCR-RFLP-pb detected more cases than the PCR-RFLP-fp  and HCT. None of the PCR techniques 
detected parasites from the Trypanozoon group. Although HCT detected more cases of T. vivax, 
species identification using PCR-RFLP-fp and PCR-RFLP-pb were significantly better than the HCT 
technique.  
The fifth chapter is presenting a six months longitudinal study conducted to evaluate 
dynamically DA resistance using microsatellite analysis to differentiate relapses from new 
infections. In addition, knowledge, attitudes and practices of livestock owners about 
trypanocidal drugs was assessed using a standardized questionnaire. The major findings of the 
study were (i) a high prevalence of the disease in the study area, (ii) a high tsetse challenge and 
(iii) a high degree of drug resistance. The questionnaire survey highlighted trypanosomosis as 
the main disease affecting cattle and DA as the main drug used in the area. Both DA and ISM 
were not properly used by farmers.  Finally, trypanosomosis control options in the Ghibe valley 
are discussed.  
In the sixth chapter, the overall findings of each research objective are discussed and 
integrated in a broader context of strategic disease control. Future prospects and research are 
proposed.  
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Trypanosomose treedt op bij verschillende zoogdieren, maar is economisch vooral van belang 
bij de veestapel, waar het op de eerste plaats wordt verspreid door tseetseevliegen. De ziekte 
belemmert in grote mate de dierlijke productie in noord en zuidwest Ethiopië in gebieden lager 
dan 2000 meter boven de zeespiegel. Net zoals in andere gebieden waar trypanosomose 
endemisch is, zijn trypanociden (medicijnen die trypanosomen doden) populair bij de 
veehouders in de Ghibe Vallei omdat ze kunnen ingezet worden bij individuele dieren en 
goedkoop en algemeen beschikbaar zijn. Het overtollige gebruik van deze trypanociden voor de 
controle van trypanosomose heeft evenwel resistentie van de trypanosomen tegen de 
trypanociden in de hand gewerkt, zoals gerapporteerd werd in verschillende gebieden in 
Ethiopië. Resistentie tegen trypanociden is het hoofdthema van deze thesis, en de objectieven 
van de thesis zijn als volgt:  i) de literatuur omtrent trypanociden resistentie in Oost Afrika 
doornemen en samenvatten, ii) het inschatten van het resistentieprobleem in de Ghibe Vallei 
voor de twee meest gebruikte trypanociden, diminazene aceturate (DA) en isometamidium 
(ISM), iii) het vergelijken van de haematocriet centrifugatie techniek (HCT) met PCR voor de 
identificatie van de aanwezigheid en het type van trypanosoma waarbij tevens gebruik gemaakt 
wordt van verschillende methoden om bloedstalen te verzamelen en te bewaren en iv) het 
evalueren van de kennis, de attitude en de werkwijze van veehouders met betrekking tot 
gebruik van trypanociden. 
 
Het eerste hoofdstuk bevat een beschrijving van de parasiet, de vector en hun interactie en 
verder wordt beschreven welke impact de ziekte op de gastheer heeft. Ook verschillende 
controlemodaliteiten worden aangehaald.  
Het tweede hoofdstuk bestaat uit een overzicht van de literatuur met betrekking tot 
trypanocide resistentie in Oost Afrika en daaraan gerelateerde problemen.   
In het derde hoofdstuk worden de resultaten van een cross-sectionele studie besproken die tot 
doel had het trypanosomose probleem in de Ghibe Vallei in kaart te brengen. De prevalentie 
van trypanosomose werd vergeleken tussen gebieden in de Ghibe Vallei  met en zonder 
controle van tseetseevliegen, en de DA en ISM resistentie werd geëvalueerd in de T. congolense 
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savannah type populatie. Daartoe werd de DpnII-PCR-RFLP tests gebruikt samen met de gouden 
standaard, i.e., de muis infectie test. Twaalf isolaten werden gekarakteriseerd aan de hand van 
de twee technieken waarbij alle isolaten resistent bleken te zijn voor beide trypanociden bij 
elke dosis. Tenslotte werd ook nog het effect van tseetseesvliegen controle in het gebied 
besproken.  
In het vierde hoofdstuk wordt een vergelijking gemaakt tussen de trypanosoom specifieke 18S-
PCR-RFLP test gebaseerd op bloedstalen die ofwel bewaard worden op  Whatman filter papier 
(PCR-RFLP-fp) of in een commercieel cell lyse en DNA beschermende buffer (PCR-RFLP-pb) 
enerzijds en de standaard haematocriet centrifugatie techniek. Met de PCR-RFLP-pb tst werden 
meer positieve stalen gevonden dan met de PCR-RFLP-fp en HCT techniek. Met de PCR 
gebaseerde technieken werden geen parasieten van de Trypanozoon groep gedetecteerd. Met 
de HCT techniek werden meer positieve T. vivax stalen gevonden maar de species identificatie 
met PCR-RFLP-fp en PCR-RFLP-pb was meer performant dan de HCT techniek.  
Het vijfde hoofdstuk houdt een bespreking in van een longitudinale studie (6 maanden 
opvolging) die werd opgezet om DA resistentie te evalueren op basis van microsatelliet analyse; 
op basis van het longitudinale karakter van de gegevens kan een onderscheid gemaakt worden 
tussen een nieuwe en een voortdurende infectie. Ook de kennis, attitude en werkwijze van 
eigenaars van vee met betrekking tot gebruik van trypanociden werd in kaart gebracht aan de 
hand van een gestandardiseerde vragenlijst. De belangrijkste bevindingen van de studie waren 
als volgt: (i) er is een hoge prevalentie van trypanosomose in het studiegebied, (ii) en ook een 
groot aantal tseetseevliegen en (iii) een hoge graad van trypanocide resistentie. Op basis van 
het bevragen van de veehouders kan geconcludeerd worden dat  trypanosomose gezien wordt 
als de belangrijkste bedreiging voor de veestapel en dat DA algemeen gebruikt wordt als 
trypanocide in het gebied. Noch DA noch ISM wordt op een correcte manier gebruikt door de 
veehouders. Tenslotte worden nog de verschillende opties om trypanosomose te controleren  
in de Ghibe vallei besproken.  
 
Samenvatting  
163 
 
In het zesde en laatste hoofdstuk worden de specifieke bevindingen per onderzoeksobjectief 
besproken en geïntegreerd in de meer algemene context van strategische ziektebeheersing. 
Tenslotte worden nog een aantal nieuwe en belangrijke onderzoekstopics opgelijst 
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